125742 S1 M5 5351 c4591001 fa interim randomization sensitive
Document text
16.1.7.2 Listing of Randomization Scheme and Actual Vaccine Received – Phase 2 Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10011081 C4591001 1001 10011081 56-85 28JUL2020 220015 Placebo 28JUL2020 Placebo 18AUG2020 Placebo 10011084 C4591001 1001 10011084 56-85 28JUL2020 220026 BNT162b2 (30 μg) 28JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 10011085 C4591001 1001 10011085 18-55 28JUL2020 40018 BNT162b2 (30 μg) 28JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 10011086 C4591001 1001 10011086 18-55 28JUL2020 40021 Placebo 28JUL2020 Placebo 18AUG2020 Placebo 10011087 C4591001 1001 10011087 18-55 28JUL2020 40032 BNT162b2 (30 μg) 28JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 10011088 C4591001 1001 10011088 18-55 28JUL2020 40047 BNT162b2 (30 μg) 28JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 10011089 C4591001 1001 10011089 18-55 28JUL2020 40070 BNT162b2 (30 μg) 28JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 10011090 C4591001 1001 10011090 56-85 29JUL2020 220087 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 10011091 C4591001 1001 10011091 18-55 29JUL2020 40171 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 10011092 C4591001 1001 10011092 18-55 29JUL2020 40172 Placebo 29JUL2020 Placebo 19AUG2020 Placebo 090177e194e7a460\Final\Final On: 14-Sep-2020 01:45 (GMT) Page 1 FDA-CBER-2021-5683-0024778 16.1.7.2 Listing of Randomization Scheme and Actual Vaccine Received – Phase 2 Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10011093 C4591001 1001 10011093 56-85 29JUL2020 220088 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 10011094 C4591001 1001 10011094 56-85 29JUL2020 220090 Placebo 29JUL2020 Placebo 20AUG2020 Placebo 10011095 C4591001 1001 10011095 18-55 29JUL2020 40178 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 10011096 C4591001 1001 10011096 56-85 29JUL2020 220095 Placebo 29JUL2020 Placebo 20AUG2020 Placebo 10011097 C4591001 1001 10011097 56-85 30JUL2020 220387 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 21AUG2020 BNT162b2 (30 μg) 10011098 C4591001 1001 10011098 56-85 30JUL2020 220393 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 10011099 C4591001 1001 10011099 56-85 30JUL2020 220389 Placebo 30JUL2020 Placebo 20AUG2020 Placebo 10011100 C4591001 1001 10011100 56-85 30JUL2020 220395 Placebo 30JUL2020 Placebo 18AUG2020 Placebo 10011101 C4591001 1001 10011101 18-55 30JUL2020 40180 Placebo 30JUL2020 Placebo 20AUG2020 Placebo 10011102 C4591001 1001 10011102 18-55 30JUL2020 40541 Placebo 30JUL2020 Placebo 20AUG2020 Placebo 090177e194e7a460\Final\Final On: 14-Sep-2020 01:45 (GMT) Page 2 FDA-CBER-2021-5683-0024779 16.1.7.2 Listing of Randomization Scheme and Actual Vaccine Received – Phase 2 Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10011103 C4591001 1001 10011103 56-85 30JUL2020 220625 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 21AUG2020 BNT162b2 (30 μg) 10011104 C4591001 1001 10011104 56-85 30JUL2020 220626 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 21AUG2020 BNT162b2 (30 μg) 10031088 C4591001 1003 10031088 18-55 27JUL2020 40003 Placebo 27JUL2020 Placebo 17AUG2020 Placebo 10031089 C4591001 1003 10031089 56-85 27JUL2020 220001 BNT162b2 (30 μg) 27JUL2020 BNT162b2 (30 μg) 17AUG2020 BNT162b2 (30 μg) 10031090 C4591001 1003 10031090 18-55 27JUL2020 40006 BNT162b2 (30 μg) 27JUL2020 BNT162b2 (30 μg) 17AUG2020 BNT162b2 (30 μg) 10031091 C4591001 1003 10031091 56-85 27JUL2020 220002 BNT162b2 (30 μg) 27JUL2020 BNT162b2 (30 μg) 17AUG2020 BNT162b2 (30 μg) 10031092 C4591001 1003 10031092 56-85 28JUL2020 220005 Placebo 28JUL2020 Placebo 18AUG2020 Placebo 10031093 C4591001 1003 10031093 56-85 28JUL2020 220011 Placebo 28JUL2020 Placebo 18AUG2020 Placebo 10031094 C4591001 1003 10031094 18-55 28JUL2020 40009 BNT162b2 (30 μg) 28JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 10031095 C4591001 1003 10031095 56-85 28JUL2020 220019 BNT162b2 (30 μg) 28JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 090177e194e7a460\Final\Final On: 14-Sep-2020 01:45 (GMT) Page 3 FDA-CBER-2021-5683-0024780 16.1.7.2 Listing of Randomization Scheme and Actual Vaccine Received – Phase 2 Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10031096 C4591001 1003 10031096 18-55 28JUL2020 40013 BNT162b2 (30 μg) 28JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 10031097 C4591001 1003 10031097 18-55 28JUL2020 40017 Placebo 28JUL2020 Placebo 18AUG2020 Placebo 10031098 C4591001 1003 10031098 56-85 28JUL2020 220023 Placebo 28JUL2020 Placebo 18AUG2020 Placebo 10031099 C4591001 1003 10031099 56-85 28JUL2020 220037 Placebo 28JUL2020 Placebo 18AUG2020 Placebo 10031100 C4591001 1003 10031100 18-55 28JUL2020 40037 Placebo 28JUL2020 Placebo 18AUG2020 Placebo 10031101 C4591001 1003 10031101 18-55 28JUL2020 40043 Placebo 28JUL2020 Placebo 18AUG2020 Placebo 10031102 C4591001 1003 10031102 56-85 28JUL2020 220039 BNT162b2 (30 μg) 28JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 10031103 C4591001 1003 10031103 56-85 29JUL2020 220124 Placebo 29JUL2020 Placebo 19AUG2020 Placebo 10031104 C4591001 1003 10031104 18-55 29JUL2020 40145 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 10031105 C4591001 1003 10031105 56-85 29JUL2020 220125 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 090177e194e7a460\Final\Final On: 14-Sep-2020 01:45 (GMT) Page 4 FDA-CBER-2021-5683-0024781 16.1.7.2 Listing of Randomization Scheme and Actual Vaccine Received – Phase 2 Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10031106 C4591001 1003 10031106 56-85 29JUL2020 220127 Placebo 29JUL2020 Placebo 19AUG2020 Placebo 10031107 C4591001 1003 10031107 56-85 29JUL2020 220132 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 10031108 C4591001 1003 10031108 56-85 29JUL2020 220219 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 10031109 C4591001 1003 10031109 56-85 30JUL2020 220223 Placebo 30JUL2020 Placebo 20AUG2020 Placebo 10031110 C4591001 1003 10031110 56-85 30JUL2020 220225 Placebo 30JUL2020 Placebo 20AUG2020 Placebo 10031111 C4591001 1003 10031111 18-55 30JUL2020 40149 Placebo 30JUL2020 Placebo 20AUG2020 Placebo 10031112 C4591001 1003 10031112 56-85 30JUL2020 220226 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 10031113 C4591001 1003 10031113 56-85 30JUL2020 220530 Placebo 30JUL2020 Placebo 20AUG2020 Placebo 10031114 C4591001 1003 10031114 56-85 30JUL2020 220531 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 10031115 C4591001 1003 10031115 18-55 30JUL2020 40151 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 090177e194e7a460\Final\Final On: 14-Sep-2020 01:45 (GMT) Page 5 FDA-CBER-2021-5683-0024782 16.1.7.2 Listing of Randomization Scheme and Actual Vaccine Received – Phase 2 Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10031117 C4591001 1003 10031117 56-85 30JUL2020 220534 Placebo 30JUL2020 Placebo 20AUG2020 Placebo 10071079 C4591001 1007 10071079 56-85 28JUL2020 220021 BNT162b2 (30 μg) 28JUL2020 BNT162b2 (30 μg) 17AUG2020 BNT162b2 (30 μg) 10071080 C4591001 1007 10071080 18-55 28JUL2020 40012 Placebo 28JUL2020 Placebo 19AUG2020 Placebo 10071081 C4591001 1007 10071081 56-85 28JUL2020 220025 Placebo 28JUL2020 Placebo 19AUG2020 Placebo 10071082 C4591001 1007 10071082 18-55 28JUL2020 40035 Placebo 28JUL2020 Placebo 19AUG2020 Placebo 10071083 C4591001 1007 10071083 18-55 28JUL2020 40026 Placebo 28JUL2020 Placebo 17AUG2020 Placebo 10071084 C4591001 1007 10071084 56-85 28JUL2020 220030 BNT162b2 (30 μg) 28JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 10071085 C4591001 1007 10071085 56-85 28JUL2020 220035 Placebo 28JUL2020 Placebo 20AUG2020 Placebo 10071086 C4591001 1007 10071086 56-85 28JUL2020 220041 BNT162b2 (30 μg) 28JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 10071087 C4591001 1007 10071087 18-55 29JUL2020 40111 Placebo 29JUL2020 Placebo 19AUG2020 Placebo 090177e194e7a460\Final\Final On: 14-Sep-2020 01:45 (GMT) Page 6 FDA-CBER-2021-5683-0024783 16.1.7.2 Listing of Randomization Scheme and Actual Vaccine Received – Phase 2 Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10071088 C4591001 1007 10071088 56-85 29JUL2020 220077 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 10071089 C4591001 1007 10071089 18-55 29JUL2020 40113 Placebo 29JUL2020 Placebo 17AUG2020 Placebo 10071090 C4591001 1007 10071090 56-85 29JUL2020 220078 Placebo 29JUL2020 Placebo 17AUG2020 Placebo 10071091 C4591001 1007 10071091 56-85 29JUL2020 220081 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 17AUG2020 BNT162b2 (30 μg) 10071092 C4591001 1007 10071092 18-55 29JUL2020 40117 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 17AUG2020 BNT162b2 (30 μg) 10071093 C4591001 1007 10071093 18-55 29JUL2020 40120 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 17AUG2020 BNT1 62b2 (30 μg) 10071094 C4591001 1007 10071094 56-85 29JUL2020 220083 Placebo 29JUL2020 Placebo 19AUG2020 Placebo 10071095 C4591001 1007 10071095 18-55 30JUL2020 40422 Placebo 30JUL2020 Placebo 17AUG2020 Placebo 10071096 C4591001 1007 10071096 18-55 30JUL2020 40425 Placebo 30JUL2020 Placebo 20AUG2020 Placebo 10071097 C4591001 1007 10071097 18-55 30JUL2020 40427 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 090177e194e7a460\Final\Final On: 14-Sep-2020 01:45 (GMT) Page 7 FDA-CBER-2021-5683-0024784 16.1.7.2 Listing of Randomization Scheme and Actual Vaccine Received – Phase 2 Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10071098 C4591001 1007 10071098 56-85 30JUL2020 220493 Placebo 30JUL2020 Placebo 20AUG2020 Placebo 10071099 C4591001 1007 10071099 56-85 30JUL2020 220499 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 10071100 C4591001 1007 10071100 18-55 30JUL2020 40430 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 10071101 C4591001 1007 10071101 56-85 30JUL2020 220496 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 10071102 C4591001 1007 10071102 18-55 30JUL2020 40639 Placebo 30JUL2020 Placebo 20AUG2020 Placebo 10131001 C4591001 1013 10131001 56-85 28JUL2020 220038 Placebo 28JUL2020 Placebo 17AUG2020 Placebo 10131002 C4591001 1013 10131002 18-55 28JUL2020 40033 BNT162b2 (30 μg) 28JUL2020 BNT162b2 (30 μg) 17AUG2020 BNT162b2 (30 μg) 10131003 C4591001 1013 10131003 18-55 28JUL2020 40056 BNT162b2 (30 μg) 28JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 10131004 C4591001 1013 10131004 56-85 28JUL2020 220049 Placebo 28JUL2020 Placebo 19AUG2020 Placebo 10131005 C4591001 1013 10131005 18-55 28JUL2020 40063 Placebo 28JUL2020 Placebo 19AUG2020 Placebo 090177e194e7a460\Final\Final On: 14-Sep-2020 01:45 (GMT) Page 8 FDA-CBER-2021-5683-0024785 16.1.7.2 Listing of Randomization Scheme and Actual Vaccine Received – Phase 2 Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10131006 C4591001 1013 10131006 18-55 28JUL2020 40057 Placebo 28JUL2020 Placebo 19AUG2020 Placebo 10131007 C4591001 1013 10131007 18-55 28JUL2020 40044 BNT162b2 (30 μg) 28JUL2020 BNT162b2 (30 μg) 17AUG2020 BNT162b2 (30 μg) 10131008 C4591001 1013 10131008 18-55 28JUL2020 40060 BNT162b2 (30 μg) 28JUL2020 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 10131009 C4591001 1013 10131009 18-55 28JUL2020 40050 Placebo 28JUL2020 Placebo 17AUG2020 Placebo 10131010 C4591001 1013 10131010 18-55 29JUL2020 40087 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 10131011 C4591001 1013 10131011 18-55 29JUL2020 40085 Placebo 29JUL2020 Placebo 17AUG2020 Placebo 10131012 C4591001 1013 10131012 18-55 29JUL2020 40129 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 10131013 C4591001 1013 10131013 18-55 29JUL2020 40123 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 10131014 C4591001 1013 10131014 18-55 29JUL2020 40092 Placebo 29JUL2020 Placebo 21AUG2020 Placebo 10131015 C4591001 1013 10131015 18-55 29JUL2020 40124 Placebo 29JUL2020 Placebo 20AUG2020 Placebo 090177e194e7a460\Final\Final On: 14-Sep-2020 01:45 (GMT) Page 9 FDA-CBER-2021-5683-0024786 16.1.7.2 Listing of Randomization Scheme and Actual Vaccine Received – Phase 2 Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10131016 C4591001 1013 10131016 18-55 29JUL2020 40094 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 21AUG2020 BNT162b2 (30 μg) 10131018 C4591001 1013 10131018 18-55 30JUL2020 40402 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 10131019 C4591001 1013 10131019 18-55 30JUL2020 40398 Placebo 30JUL2020 Placebo 18AUG2020 Placebo 10131020 C4591001 1013 10131020 18-55 30JUL2020 40404 Placebo 30JUL2020 Placebo 19AUG2020 Placebo 10131021 C4591001 1013 10131021 18-55 30JUL2020 40407 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 25AUG2020 BNT162b2 (30 μg) 10131022 C4591001 1013 10131022 18-55 30JUL2020 40417 BNT162b2 (30 μ g) 30JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 10131023 C4591001 1013 10131023 18-55 30JUL2020 40413 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 10131024 C4591001 1013 10131024 18-55 30JUL2020 40416 Placebo 30JUL2020 Placebo 18AUG2020 Placebo 10131025 C4591001 1013 10131025 18-55 30JUL2020 40419 Placebo 30JUL2020 Placebo 18AUG2020 Placebo 10131026 C4591001 1013 10131026 18-55 30JUL2020 40493 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 090177e194e7a460\Final\Final On: 14-Sep-2020 01:45 (GMT) Page 10 FDA-CBER-2021-5683-0024787 16.1.7.2 Listing of Randomization Scheme and Actual Vaccine Received – Phase 2 Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10131028 C4591001 1013 10131028 56-85 30JUL2020 220409 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 10131029 C4591001 1013 10131029 56-85 30JUL2020 220414 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 10131030 C4591001 1013 10131030 18-55 30JUL2020 40497 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 10131031 C4591001 1013 10131031 18-55 30JUL2020 40500 Placebo 30JUL2020 Placebo 18AUG2020 Placebo 10131032 C4591001 1013 10131032 18-55 30JUL2020 40504 Placebo 30JUL2020 Placebo 19AUG2020 Placebo 10161001 C4591001 1016 10161001 56-85 29JUL2020 220097 Placebo 29JUL2020 Placebo 18AUG2020 Placebo 10161002 C4591001 1016 10161002 56-85 29JUL2020 220098 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 10161003 C4591001 1016 10161003 18-55 29JUL2020 40137 Placebo 29JUL2020 Placebo 19AUG2020 Placebo 10161004 C4591001 1016 10161004 18-55 29JUL2020 40139 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 10161005 C4591001 1016 10161005 18-55 29JUL2020 40142 Placebo 29JUL2020 Placebo 17AUG2020 Placebo 090177e194e7a460\Final\Final On: 14-Sep-2020 01:45 (GMT) Page 11 FDA-CBER-2021-5683-0024788 16.1.7.2 Listing of Randomization Scheme and Actual Vaccine Received – Phase 2 Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10161006 C4591001 1016 10161006 18-55 29JUL2020 40144 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 10161007 C4591001 1016 10161007 56-85 29JUL2020 220101 Placebo 29JUL2020 Placebo 18AUG2020 Placebo 10161009 C4591001 1016 10161009 18-55 30JUL2020 40433 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 10161010 C4591001 1016 10161010 18-55 30JUL2020 40434 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 10161011 C4591001 1016 10161011 56-85 30JUL2020 220105 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 10161012 C4591001 1016 10161012 56-85 30JUL2020 220433 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 21AUG2020 BNT162b2 (30 μg) 10161013 C4591001 1016 10161013 56-85 30JUL2020 220436 Placebo 30JUL2020 Placebo 18AUG2020 Placebo 10161014 C4591001 1016 10161014 18-55 30JUL2020 40440 Placebo 30JUL2020 Placebo 19AUG2020 Placebo 10161015 C4591001 1016 10161015 56-85 30JUL2020 220438 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 10161016 C4591001 1016 10161016 56-85 30JUL2020 220442 Placebo 30JUL2020 Placebo 20AUG2020 Placebo 090177e194e7a460\Final\Final On: 14-Sep-2020 01:45 (GMT) Page 12 FDA-CBER-2021-5683-0024789 16.1.7.2 Listing of Randomization Scheme and Actual Vaccine Received – Phase 2 Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10181001 C4591001 1018 10181001 18-55 29JUL2020 40193 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 10181002 C4591001 1018 10181002 56-85 29JUL2020 220183 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 10181003 C4591001 1018 10181003 18-55 29JUL2020 40194 Placebo 29JUL2020 Placebo 19AUG2020 Placebo 10181004 C4591001 1018 10181004 56-85 29JUL2020 220186 Placebo 29JUL2020 Placebo 19AUG2020 Placebo 10181005 C4591001 1018 10181005 56-85 29JUL2020 220188 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 10181006 C4591001 1018 10181006 56-85 29JUL2020 220192 Placebo 29JUL2020 Placebo 19AUG2020 Placebo 10181007 C4591001 1018 10181007 18-55 29JUL2020 40199 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 10421001 C4591001 1042 10421001 18-55 29JUL2020 40290 Placebo 29JUL2020 Placebo 19AUG2020 Placebo 10421002 C4591001 1042 10421002 56-85 29JUL2020 220340 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 17AUG2020 BNT162b2 (30 μg) 10421003 C4591001 1042 10421003 18-55 29JUL2020 40293 Placebo 29JUL2020 Placebo 17AUG2020 Placebo 090177e194e7a460\Final\Final On: 14-Sep-2020 01:45 (GMT) Page 13 FDA-CBER-2021-5683-0024790 16.1.7.2 Listing of Randomization Scheme and Actual Vaccine Received – Phase 2 Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10421004 C4591001 1042 10421004 18-55 29JUL2020 40295 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 21AUG2020 BNT162b2 (30 μg) 10421008 C4591001 1042 10421008 18-55 30JUL2020 40296 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 21AUG2020 BNT162b2 (30 μg) 10421009 C4591001 1042 10421009 56-85 30JUL2020 220341 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 10731001 C4591001 1073 10731001 56-85 29JUL2020 220302 Placebo 29JUL2020 Placebo 19AUG2020 Placebo 10731002 C4591001 1073 10731002 56-85 29JUL2020 220303 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 10731003 C4591001 1073 10731003 56-85 29JUL2020 220306 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 10731004 C4591001 1073 10731004 56-85 29JUL2020 220311 Placebo 29JUL2020 Placebo 19AUG2020 Placebo 10731005 C4591001 1073 10731005 56-85 29JUL2020 220319 Placebo 29JUL2020 Placebo 19AUG2020 Placebo 10731006 C4591001 1073 10731006 18-55 30JUL2020 40529 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 10731007 C4591001 1073 10731007 56-85 30JUL2020 220320 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 090177e194e7a460\Final\Final On: 14-Sep-2020 01:45 (GMT) Page 14 FDA-CBER-2021-5683-0024791 16.1.7.2 Listing of Randomization Scheme and Actual Vaccine Received – Phase 2 Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10731008 C4591001 1073 10731008 18-55 30JUL2020 40530 Placebo 30JUL2020 Placebo 20AUG2020 Placebo 10731009 C4591001 1073 10731009 18-55 30JUL2020 40535 Placebo 30JUL2020 Placebo 24AUG2020 Placebo 10731010 C4591001 1073 10731010 56-85 30JUL2020 220323 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 10731011 C4591001 1073 10731011 56-85 30JUL2020 220324 Placebo 30JUL2020 Placebo 20AUG2020 Placebo 10731012 C4591001 1073 10731012 18-55 30JUL2020 40537 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 10731013 C4591001 1073 10731013 18-55 30JUL2020 40722 Placebo 30JUL2020 Placebo 20AUG2020 Placebo 10731014 C4591001 1073 10731014 56-85 30JUL2020 220771 Placebo 30JUL2020 Placebo 20AUG2020 Placebo 10791001 C4591001 1079 10791001 56-85 29JUL2020 220231 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 21AUG2020 BNT162b2 (30 μg) 10791002 C4591001 1079 10791002 18-55 29JUL2020 40279 Placebo 29JUL2020 Placebo 19AUG2020 Placebo 10791003 C4591001 1079 10791003 18-55 29JUL2020 40282 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 17AUG2020 BNT162b2 (30 μg) 090177e194e7a460\Final\Final On: 14-Sep-2020 01:45 (GMT) Page 15 FDA-CBER-2021-5683-0024792 16.1.7.2 Listing of Randomization Scheme and Actual Vaccine Received – Phase 2 Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10791004 C4591001 1079 10791004 18-55 29JUL2020 40283 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 10791005 C4591001 1079 10791005 56-85 29JUL2020 220232 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 10791006 C4591001 1079 10791006 56-85 29JUL2020 220234 Placebo 29JUL2020 Placebo 17AUG2020 Placebo 10791007 C4591001 1079 10791007 18-55 29JUL2020 40285 Placebo 29JUL2020 Placebo 17AUG2020 Placebo 10791008 C4591001 1079 10791008 18-55 29JUL2020 40301 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 10791009 C4591001 1079 10791009 56-85 30JUL2020 220240 Placebo 30JUL2020 Placebo 18AUG2020 Placebo 10791010 C4591001 1079 10791010 18-55 30JUL2020 40303 Placebo 30JUL2020 Placebo 20AUG2020 Placebo 10791011 C4591001 1079 10791011 56-85 30JUL2020 220637 Placebo 30JUL2020 Placebo 18AUG2020 Placebo 10791013 C4591001 1079 10791013 18-55 30JUL2020 40306 Placebo 30JUL2020 Placebo 19AUG2020 Placebo 10791014 C4591001 1079 10791014 56-85 30JUL2020 220646 Placebo 30JUL2020 Placebo 20AUG2020 Placebo 090177e194e7a460\Final\Final On: 14-Sep-2020 01:45 (GMT) Page 16 FDA-CBER-2021-5683-0024793 16.1.7.2 Listing of Randomization Scheme and Actual Vaccine Received – Phase 2 Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10821001 C4591001 1082 10821001 56-85 30JUL2020 220376 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 10821002 C4591001 1082 10821002 56-85 30JUL2020 220379 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 10821003 C4591001 1082 10821003 18-55 30JUL2020 40519 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 10821004 C4591001 1082 10821004 18-55 30JUL2020 40521 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 10831001 C4591001 1083 10831001 18-55 29JUL2020 40326 Placebo 29JUL2020 Placebo 21AUG2020 Placebo 10831002 C4591001 1083 10831002 18-55 29JUL2020 40331 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 21AUG2020 BNT162b2 (30 μg) 10831003 C4591001 1083 10831003 56-85 29JUL2020 220349 Placebo 29JUL2020 Placebo 21AUG2020 Placebo 10831004 C4591001 1083 10831004 18-55 29JUL2020 40333 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 21AUG2020 BNT162b2 (30 μg) 10831005 C4591001 1083 10831005 18-55 29JUL2020 40336 Placebo 29JUL2020 Placebo 21AUG2020 Placebo 10831006 C4591001 1083 10831006 18-55 29JUL2020 40362 Placebo 29JUL2020 Placebo 21AUG2020 Placebo 090177e194e7a460\Final\Final On: 14-Sep-2020 01:45 (GMT) Page 17 FDA-CBER-2021-5683-0024794 16.1.7.2 Listing of Randomization Scheme and Actual Vaccine Received – Phase 2 Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10841001 C4591001 1084 10841001 18-55 30JUL2020 40590 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 10841002 C4591001 1084 10841002 56-85 30JUL2020 220615 Placebo 30JUL2020 Placebo 18AUG2020 Placebo 10841003 C4591001 1084 10841003 18-55 30JUL2020 40591 Placebo 30JUL2020 Placebo 21AUG2020 Placebo 10841006 C4591001 1084 10841006 56-85 30JUL2020 220618 Placebo 30JUL2020 Placebo 17AUG2020 Placebo 10851001 C4591001 1085 10851001 56-85 30JUL2020 220505 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 10851002 C4591001 1085 10851002 56-85 30JUL2020 220506 Placebo 30JUL2020 Placebo 20AUG2020 Placebo 10851003 C4591001 1085 10851003 18-55 30JUL2020 40554 Placebo 30JUL2020 Placebo 21AUG2020 Placebo 10851004 C4591001 1085 10851004 18-55 30JUL2020 40555 Placebo 30JUL2020 Placebo 20AUG2020 Placebo 10851005 C4591001 1085 10851005 56-85 30JUL2020 220514 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 10851006 C4591001 1085 10851006 56-85 30JUL2020 220516 Placebo 30JUL2020 Placebo 20AUG2020 Placebo 090177e194e7a460\Final\Final On: 14-Sep-2020 01:45 (GMT) Page 18 FDA-CBER-2021-5683-0024795 16.1.7.2 Listing of Randomization Scheme and Actual Vaccine Received – Phase 2 Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10851007 C4591001 1085 10851007 56-85 30JUL2020 40556 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 10851008 C4591001 1085 10851008 56-85 30JUL2020 40564 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 10891001 C4591001 1089 10891001 56-85 29JUL2020 220201 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 10891002 C4591001 1089 10891002 56-85 29JUL2020 220202 Placebo 29JUL2020 Placebo 19AUG2020 Placebo 10891003 C4591001 1089 108910 03 56-85 29JUL2020 220203 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 10891004 C4591001 1089 10891004 56-85 29JUL2020 220204 Placebo 29JUL2020 Placebo 10891005 C4591001 1089 10891005 56-85 29JUL2020 220265 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 10891006 C4591001 1089 10891006 56-85 29JUL2020 220267 Placebo 29JUL2020 Placebo 17AUG2020 Placebo 10891007 C4591001 1089 10891007 56-85 29JUL2020 220268 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 17AUG2020 BNT162b2 (30 μg) 10891008 C4591001 1089 10891008 56-85 29JUL2020 220272 Placebo 29JUL2020 Placebo 18AUG2020 Placebo 090177e194e7a460\Final\Final On: 14-Sep-2020 01:45 (GMT) Page 19 FDA-CBER-2021-5683-0024796 16.1.7.2 Listing of Randomization Scheme and Actual Vaccine Received – Phase 2 Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10891009 C4591001 1089 10891009 56-85 30JUL2020 220566 Placebo 30JUL2020 Placebo 18AUG2020 Placebo 10891011 C4591001 1089 10891011 18-55 30JUL2020 40567 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 10891012 C4591001 1089 10891012 56-85 30JUL2020 220571 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 10891013 C4591001 1089 10891013 18-55 30JUL2020 40569 Placebo 30JUL2020 Placebo 18AUG2020 Placebo 10891014 C4591001 1089 10891014 56-85 30JUL2020 220572 Placebo 30JUL2020 Placebo 18AUG2020 Placebo 10891015 C4591001 1089 10891015 18-55 30JUL2020 40572 Placebo 30JUL2020 Placebo 18AUG2020 Placebo 10891016 C4591001 1089 10891016 56-85 30JUL2020 220574 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 10951001 C4591001 1095 10951001 18-55 30JUL2020 40449 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 10951002 C4591001 1095 10951002 18-55 30JUL2020 40445 Placebo 30JUL2020 Placebo 21AUG2020 Placebo 10951003 C4591001 1095 10951003 56-85 30JUL2020 220591 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 090177e194e7a460\Final\Final On: 14-Sep-2020 01:45 (GMT) Page 20 FDA-CBER-2021-5683-0024797 16.1.7.2 Listing of Randomization Scheme and Actual Vaccine Received – Phase 2 Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10951004 C4591001 1095 10951004 56-85 30JUL2020 220589 Placebo 30JUL2020 Placebo 20AUG2020 Placebo 10951005 C4591001 1095 10951005 18-55 30JUL2020 40452 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 10951006 C4591001 1095 10951006 18-55 30JUL2020 40455 Placebo 30JUL2020 Placebo 20AUG2020 Placebo 10951007 C4591001 1095 10951007 18-55 30JUL2020 40697 Placebo 30JUL2020 Placebo 18AUG2020 Placebo 11071001 C4591001 1107 11071001 56-85 29JUL2020 220281 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 11071003 C4591001 1107 11071003 18-55 29JUL2020 40317 Placebo 29JUL2020 Placebo 18AUG2020 Placebo 11071004 C4591001 1107 11071004 56-85 30JUL2020 220285 Placebo 30JUL2020 Placebo 18AUG2020 Placebo 11071005 C4591001 1107 11071005 56-85 30JUL2020 220287 Placebo 30JUL2020 Placebo 20AUG2020 Placebo 11071006 C4591001 1107 11071006 18-55 30JUL2020 40319 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 11071007 C4591001 1107 11071007 56-85 30JUL2020 220579 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 090177e194e7a460\Final\Final On: 14-Sep-2020 01:45 (GMT) Page 21 FDA-CBER-2021-5683-0024798 16.1.7.2 Listing of Randomization Scheme and Actual Vaccine Received – Phase 2 Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 11071008 C4591001 1107 11071008 56-85 30JUL2020 220587 Placebo 30JUL2020 Placebo 20AUG2020 Placebo 11071009 C4591001 1107 11071009 56-85 30JUL2020 220581 Placebo 30JUL2020 Placebo 20AUG2020 Placebo 11071010 C4591001 1107 11071010 18-55 30JUL2020 40320 Placebo 30JUL2020 Placebo 18AUG2020 Placebo 11091001 C4591001 1109 11091001 18-55 29JUL2020 40243 Placebo 29JUL2020 Placebo 17AUG2020 Placebo 11091002 C4591001 1109 11091002 18-55 29JUL2020 40249 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 17AUG2020 BNT162b2 (30 μg) 11091003 C4591001 1109 11091003 18-55 29JUL2020 40244 Placebo 29JUL2020 Placebo 18AUG2020 Placebo 11091004 C4591001 1109 11091004 18-55 29JUL2020 40266 Placebo 29JUL2020 Placebo 17AUG2020 Placebo 11091005 C4591001 1109 11091005 56-85 29JUL2020 220253 Placebo 29JUL2020 Placebo 17AUG2020 Placebo 11091006 C4591001 1109 11091006 18-55 29JUL2020 40251 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 26AUG2020 BNT162b2 (30 μg) 11091007 C4591001 1109 11091007 18-55 29JUL2020 40267 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 21AUG2020 BNT162b2 (30 μg) 090177e194e7a460\Final\Final On: 14-Sep-2020 01:45 (GMT) Page 22 FDA-CBER-2021-5683-0024799 16.1.7.2 Listing of Randomization Scheme and Actual Vaccine Received – Phase 2 Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 11091008 C4591001 1109 11091008 56-85 29JUL2020 220256 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 11091009 C4591001 1109 11091009 56-85 29JUL2020 220261 Placebo 29JUL2020 Placebo 21AUG2020 Placebo 11091010 C4591001 1109 11091010 18-55 29JUL2020 40271 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 17AUG2020 BNT162b2 (30 μg) 11091011 C4591001 1109 11091011 18-55 29JUL2020 40270 Placebo 29JUL2020 Placebo 17AUG2020 Placebo 11091012 C4591001 1109 11091012 56-85 29JUL2020 220264 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 11091013 C4591001 1109 11091013 18-55 29JUL2020 40339 Placebo 29JUL2020 Placebo 17AUG2020 Placebo 11091014 C4591001 1109 11091014 18-55 29JUL2020 40343 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 26AUG2020 BNT162b2 (30 μg) 11091015 C4591001 1109 11091015 18-55 29JUL2020 40346 Placebo 29JUL2020 Placebo 18AUG2020 Placebo 11091016 C4591001 1109 11091016 18-55 30JUL2020 40382 Placebo 30JUL2020 Placebo 18AUG2020 Placebo 11091017 C4591001 1109 11091017 18-55 30JUL2020 40348 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 090177e194e7a460\Final\Final On: 14-Sep-2020 01:45 (GMT) Page 23 FDA-CBER-2021-5683-0024800 16.1.7.2 Listing of Randomization Scheme and Actual Vaccine Received – Phase 2 Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 11091018 C4591001 1109 11091018 18-55 30JUL2020 40373 Placebo 30JUL2020 Placebo 18AUG2020 Placebo 11091019 C4591001 1109 11091019 18-55 30JUL2020 40377 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 21AUG2020 BNT162b2 (30 μg) 11091020 C4591001 1109 11091020 18-55 30JUL2020 40384 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 11091021 C4591001 1109 11091021 18-55 30JUL2020 40387 Placebo 30JUL2020 Placebo 21AUG2020 Placebo 11091022 C4591001 1109 11091022 18-55 30JUL2020 40388 Placebo 30JUL2020 Placebo 18AUG2020 Placebo 11091023 C4591001 1109 11091023 18-55 30JUL2020 40394 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 21AUG2020 BNT162b2 (30 μg) 11091024 C4591001 1109 11091024 18-55 30JUL2020 40396 BNT162b2 (30 μg ) 30JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 11091025 C4591001 1109 11091025 56-85 30JUL2020 220518 Placebo 30JUL2020 Placebo 18AUG2020 Placebo 11091026 C4591001 1109 11091026 56-85 30JUL2020 220523 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μ g) 18AUG2020 BNT162b2 (30 μg) 11091027 C4591001 1109 11091027 18-55 30JUL2020 40505 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 21AUG2020 BNT162b2 (30 μg) 090177e194e7a460\Final\Final On: 14-Sep-2020 01:45 (GMT) Page 24 FDA-CBER-2021-5683-0024801 16.1.7.2 Listing of Randomization Scheme and Actual Vaccine Received – Phase 2 Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 11091028 C4591001 1109 11091028 18-55 30JUL2020 40506 Placebo 30JUL2020 Placebo 21AUG2020 Placebo 11091029 C4591001 1109 11091029 56-85 30JUL2020 220517 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 22AUG2020 BNT162b2 (30 μg) 11091030 C4591001 1109 11091030 18-55 30JUL2020 40507 Placebo 30JUL2020 Placebo 18AUG2020 Placebo 11091031 C4591001 1109 11091031 56-85 30JUL2020 220520 Placebo 30JUL2020 Placebo 18AUG2020 Placebo 11091032 C4591001 1109 11091032 56-85 30JUL2020 220687 Placebo 30JUL2020 Placebo 18AUG2020 Placebo 11091033 C4591001 1109 11091033 18-55 30JUL2020 40515 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 11111001 C4591001 1111 11111001 18-55 30JUL2020 40473 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 11111002 C4591001 1111 11111002 56-85 30JUL2020 220448 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 11111003 C4591001 1111 11111003 56-85 30JUL2020 220449 Placebo 30JUL2020 Placebo 20AUG2020 Placebo 11111004 C4591001 1111 11111004 56-85 30JUL2020 220450 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 090177e194e7a460\Final\Final On: 14-Sep-2020 01:45 (GMT) Page 25 FDA-CBER-2021-5683-0024802 16.1.7.2 Listing of Randomization Scheme and Actual Vaccine Received – Phase 2 Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 11111005 C4591001 1111 11111005 56-85 30JUL2020 220452 Placebo 30JUL2020 Placebo 21AUG2020 Placebo 11121001 C4591001 1112 11121001 56-85 29JUL2020 220110 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 11121002 C4591001 1112 11121002 56-85 29JUL2020 220111 Placebo 29JUL2020 Placebo 19AUG2020 Placebo 11121003 C4591001 1112 11121003 56-85 29JUL2020 220120 Placebo 29JUL2020 Placebo 19AUG2020 Placebo 11121004 C4591001 1112 11121004 18-55 29JUL2020 40208 Placebo 29JUL2020 Placebo 19AUG2020 Placebo 11121005 C4591001 1112 11121005 56-85 29JUL2020 220115 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 11121006 C4591001 1112 11121006 18-55 29JUL2020 40214 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 11121007 C4591001 1112 11121007 56-85 29JUL2020 220296 Placebo 29JUL2020 Placebo 19AUG2020 Placebo 11121008 C4591001 1112 11121008 18-55 29JUL2020 40215 Placebo 29JUL2020 Placebo 19AUG2020 Placebo 11121009 C4591001 1112 11121009 18-55 30JUL2020 40216 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 090177e194e7a460\Final\Final On: 14-Sep-2020 01:45 (GMT) Page 26 FDA-CBER-2021-5683-0024803 16.1.7.2 Listing of Randomization Scheme and Actual Vaccine Received – Phase 2 Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 11121010 C4591001 1112 11121010 56-85 30JUL2020 220297 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 11121011 C4591001 1112 11121011 18-55 30JUL2020 40482 Placebo 30JUL2020 Placebo 20AUG2020 Placebo 11121012 C4591001 1112 11121012 18-55 30JUL2020 40485 Placebo 30JUL2020 Placebo 21AUG2020 Placebo 11121013 C4591001 1112 11121013 18-55 30JUL2020 40486 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 11121015 C4591001 1112 11121015 18-55 30JUL2020 40674 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 11121016 C4591001 1112 11121016 18-55 30JUL2020 40487 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 11201001 C4591001 1120 11201001 18-55 29JUL2020 40349 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 11201002 C4591001 1120 11201002 56-85 29JUL2020 220363 Placebo 29JUL2020 Placebo 19AUG2020 Placebo 11201003 C4591001 1120 11201003 56-85 29JUL2020 220361 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 11201006 C4591001 1120 11201006 56-85 29JUL2020 220362 Placebo 29JUL2020 Placebo 21AUG2020 Placebo 090177e194e7a460\Final\Final On: 14-Sep-2020 01:45 (GMT) Page 27 FDA-CBER-2021-5683-0024804 16.1.7.2 Listing of Randomization Scheme and Actual Vaccine Received – Phase 2 Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 11201007 C4591001 1120 11201007 56-85 29JUL2020 220366 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 11231001 C4591001 1123 11231001 18-55 29JUL2020 40221 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 21AUG2020 BNT162b2 (30 μg) 11231002 C4591001 1123 11231002 18-55 30JUL2020 40223 Placebo 30JUL2020 Placebo 18AUG2020 Placebo 11231003 C4591001 1123 11231003 18-55 30JUL2020 40225 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 11271001 C4591001 1127 11271001 56-85 29JUL2020 220147 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 17AUG2020 BNT162b2 (30 μg) 11271002 C4591001 1127 11271002 56-85 29JUL2020 220152 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 16AUG2020 BNT162b2 (30 μg) 11271003 C4591001 1127 11271003 56-85 29JUL2020 220155 Placebo 29JUL2020 Placebo 16AUG2020 Placebo 11271004 C4591001 1127 11271004 18-55 29JUL2020 40230 Placebo 29JUL2020 Placebo 17AUG2020 Placebo 11271005 C4591001 1127 11271005 56-85 29JUL2020 220207 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 17AUG2020 BNT162b2 (30 μg) 11271006 C4591001 1127 11271006 56-85 29JUL2020 220156 Placebo 29JUL2020 Placebo 17AUG2020 Placebo 090177e194e7a460\Final\Final On: 14-Sep-2020 01:45 (GMT) Page 28 FDA-CBER-2021-5683-0024805 16.1.7.2 Listing of Randomization Scheme and Actual Vaccine Received – Phase 2 Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 11271007 C4591001 1127 11271007 56-85 29JUL2020 220206 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 11271008 C4591001 1127 11271008 56-85 29JUL2020 220214 Placebo 29JUL2020 Placebo 18AUG2020 Placebo 11271009 C4591001 1127 11271009 56-85 30JUL2020 220460 Placebo 30JUL2020 Placebo 18AUG2020 Placebo 11271010 C4591001 1127 11271010 56-85 30JUL2020 220216 Placebo 30JUL2020 Placebo 18AUG2020 Placebo 11271011 C4591001 1127 11271011 18-55 30JUL2020 40234 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 11271012 C4591001 1127 11271012 56-85 30JUL2020 220461 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 11271014 C4591001 1127 11271014 18-55 30JUL2020 40613 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 11271015 C4591001 1127 11271015 18-55 30JUL2020 40235 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 11271016 C4591001 1127 11271016 18-55 30JUL2020 40238 Placebo 30JUL2020 Placebo 18AUG2020 Placebo 11271017 C4591001 1127 11271017 18-55 30JUL2020 40619 Placebo 30JUL2020 Placebo 18AUG2020 Placebo 090177e194e7a460\Final\Final On: 14-Sep-2020 01:45 (GMT) Page 29 FDA-CBER-2021-5683-0024806 16.1.7.2 Listing of Randomization Scheme and Actual Vaccine Received – Phase 2 Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 11291001 C4591001 1129 11291001 18-55 29JUL2020 40183 Placebo 29JUL2020 Placebo 19AUG2020 Placebo 11291002 C4591001 1129 11291002 56-85 29JUL2020 220159 Placebo 29JUL2020 Placebo 19AUG2020 Placebo 11291003 C4591001 1129 11291003 56-85 29JUL2020 220164 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 11291004 C4591001 1129 11291004 56-85 29JUL2020 220165 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 11291005 C4591001 1129 11291005 18-55 29JUL2020 40184 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 11291006 C4591001 1129 11291006 18-55 29JUL2020 40188 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 17AUG2020 BNT162b2 (30 μg) 11291007 C4591001 1129 11291007 56-85 29JUL2020 220166 Placebo 29JUL2020 Placebo 17AUG2020 Placebo 11291008 C4591001 1129 11291008 56-85 29JUL2020 220325 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 17AUG2020 BNT162b2 (30 μg) 11291009 C4591001 1129 11291009 56-85 30JUL2020 220332 Placebo 30JUL2020 Placebo 19AUG2020 Placebo 11291010 C4591001 1129 11291010 18-55 30JUL2020 40192 Placebo 30JUL2020 Placebo 19AUG2020 Placebo 090177e194e7a460\Final\Final On: 14-Sep-2020 01:45 (GMT) Page 30 FDA-CBER-2021-5683-0024807 16.1.7.2 Listing of Randomization Scheme and Actual Vaccine Received – Phase 2 Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 11291011 C4591001 1129 11291011 56-85 30JUL2020 220334 Placebo 30JUL2020 Placebo 19AUG2020 Placebo 11291012 C4591001 1129 11291012 56-85 30JUL2020 220336 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 11291013 C4591001 1129 11291013 56-85 30JUL2020 220481 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 11291014 C4591001 1129 11291014 18-55 30JUL2020 40626 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 11291015 C4591001 1129 11291015 56-85 30JUL2020 220484 Placebo 30JUL2020 Placebo 18AUG2020 Placebo 11291016 C4591001 1129 11291016 56-85 30JUL2020 220489 Placebo 30JUL2020 Placebo 18AUG2020 Placebo 11331001 C4591001 1133 11331001 18-55 30JUL2020 40463 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 21AUG2020 BNT162b2 (30 μg) 11331002 C4591001 1133 11331002 56-85 30JUL2020 220397 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 21AUG2020 BNT162b2 (30 μg) 11331003 C4591001 1133 11331003 18-55 30JUL2020 40466 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 21AUG2020 BNT162b2 (30 μg) 11331004 C4591001 1133 11331004 18-55 30JUL2020 40465 Placebo 30JUL2020 Placebo 21AUG2020 Placebo 090177e194e7a460\Final\Final On: 14-Sep-2020 01:45 (GMT) Page 31 FDA-CBER-2021-5683-0024808 16.1.7.2 Listing of Randomization Scheme and Actual Vaccine Received – Phase 2 Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 11331005 C4591001 1133 11331005 56-85 30JUL2020 220400 Placebo 30JUL2020 Placebo 21AUG2020 Placebo 11331007 C4591001 1133 11331007 56-85 30JUL2020 220403 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 21AUG2020 BNT162b2 (30 μg) 11331008 C4591001 1133 11331008 56-85 30JUL2020 220554 Placebo 30JUL2020 Placebo 21AUG2020 Placebo 11331009 C4591001 1133 11331009 56-85 30JUL2020 220401 Placebo 30JUL2020 Placebo 21AUG2020 Placebo 11331010 C4591001 1133 11331010 56-85 30JUL2020 220553 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 21AUG2020 BNT162b2 (30 μg) 11331011 C4591001 1133 11331011 18-55 30JUL2020 40467 Placebo 30JUL2020 Placebo 21AUG2020 Placebo 11331012 C4591001 1133 11331012 56-85 30JUL2020 220561 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 21AUG2020 BNT162b2 (30 μg) 11331013 C4591001 1133 11331013 56-85 30JUL2020 220563 Placebo 30JUL2020 Placebo 21AUG2020 Placebo 11331014 C4591001 1133 11331014 18-55 30JUL2020 40650 Placebo 30JUL2020 Placebo 21AUG2020 Placebo 11331016 C4591001 1133 11331016 18-55 30JUL2020 40651 Placebo 30JUL2020 Placebo 24AUG2020 Placebo 090177e194e7a460\Final\Final On: 14-Sep-2020 01:45 (GMT) Page 32 FDA-CBER-2021-5683-0024809 16.1.7.2 Listing of Randomization Scheme and Actual Vaccine Received – Phase 2 Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 11391001 C4591001 1139 11391001 18-55 29JUL2020 40075 Placebo 29JUL2020 Placebo 20AUG2020 Placebo 11391002 C4591001 1139 11391002 56-85 29JUL2020 220061 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 11391003 C4591001 1139 11391003 56-85 29JUL2020 220062 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 11391004 C4591001 1139 11391004 56-85 29JUL2020 220068 Placebo 29JUL2020 Placebo 20AUG2020 Placebo 11391005 C4591001 1139 11391005 56-85 29JUL2020 220071 Placebo 29JUL2020 Placebo 20AUG2020 Placebo 11391006 C4591001 1139 11391006 56-85 29JUL2020 220175 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 21AUG2020 BNT162b2 (30 μg) 11391007 C4591001 1139 11391007 18-55 29JUL2020 40076 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 11391008 C4591001 1139 11391008 56-85 29JUL2020 220177 Placebo 29JUL2020 Placebo 20AUG2020 Placebo 11391009 C4591001 1139 11391009 56-85 29JUL2020 220178 Placebo 29JUL2020 Placebo 20AUG2020 Placebo 11391010 C4591001 1139 11391010 18-55 29JUL2020 40078 Placebo 29JUL2020 Placebo 20AUG2020 Placebo 090177e194e7a460\Final\Final On: 14-Sep-2020 01:45 (GMT) Page 33 FDA-CBER-2021-5683-0024810 16.1.7.2 Listing of Randomization Scheme and Actual Vaccine Received – Phase 2 Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 11391011 C4591001 1139 11391011 56-85 30JUL2020 220180 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 11391012 C4591001 1139 11391012 56-85 30JUL2020 220421 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 11391013 C4591001 1139 11391013 56-85 30JUL2020 220423 Placebo 30JUL2020 Placebo 19AUG2020 Placebo 11391014 C4591001 1139 11391014 56-85 30JUL2020 220425 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 21AUG2020 BNT162b2 (30 μg) 11391015 C4591001 1139 11391015 18-55 30JUL2020 40084 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 21AUG2020 BNT162b2 (30 μg) 11401001 C4591001 1140 11401001 18-55 29JUL2020 40099 Placebo 29JUL2020 Placebo 19AUG2020 Placebo 11401002 C4591001 1140 11401002 56-85 29JUL2020 220241 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 17AUG2020 BNT162b2 (30 μg) 11401003 C4591001 1140 11401003 56-85 29JUL2020 220245 Placebo 29JUL2020 Placebo 17AUG2020 Placebo 11401004 C4591001 1140 11401004 56-85 29JUL2020 220246 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 17AUG2020 BNT162b2 (30 μg) 11401005 C4591001 1140 11401005 56-85 30JUL2020 220251 Placebo 30JUL2020 Placebo 18AUG2020 Placebo 090177e194e7a460\Final\Final On: 14-Sep-2020 01:45 (GMT) Page 34 FDA-CBER-2021-5683-0024811 16.1.7.2 Listing of Randomization Scheme and Actual Vaccine Received – Phase 2 Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 11401006 C4591001 1140 11401006 18-55 30JUL2020 40103 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 11401007 C4591001 1140 11401007 56-85 30JUL2020 220541 Placebo 30JUL2020 Placebo 19AUG2020 Placebo 11401008 C4591001 1140 11401008 56-85 30JUL2020 220542 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 11411001 C4591001 1141 11411001 56-85 30JUL2020 220469 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 11421001 C4591001 1142 11421001 18-55 29JUL2020 40157 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 17AUG2020 BNT162b2 (30 μg) 11421002 C4591001 1142 11421002 18-55 29JUL2020 40160 Placebo 29JUL2020 Placebo 19AUG2020 Placebo 11421003 C4591001 1142 11421003 56-85 29JUL2020 220134 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 17AUG2020 BNT162b2 (30 μg) 11421004 C4591001 1142 11421004 18-55 29JUL2020 40167 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 17AUG2020 BNT162b2 (30 μg) 11421005 C4591001 1142 11421005 56-85 29JUL2020 220135 Placebo 29JUL2020 Placebo 17AUG2020 Placebo 11421006 C4591001 1142 11421006 56-85 29JUL2020 220136 Placebo 29JUL2020 Placebo 17AUG2020 Placebo 090177e194e7a460\Final\Final On: 14-Sep-2020 01:45 (GMT) Page 35 FDA-CBER-2021-5683-0024812 16.1.7.2 Listing of Randomization Scheme and Actual Vaccine Received – Phase 2 Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 11421007 C4591001 1142 11421007 18-55 29JUL2020 40168 Placebo 29JUL2020 Placebo 17AUG2020 Placebo 11421008 C4591001 1142 11421008 18-55 29JUL2020 40254 Placebo 29JUL2020 Placebo 17AUG2020 Placebo 11421010 C4591001 1142 11421010 18-55 30JUL2020 40259 Placebo 30JUL2020 Placebo 18AUG2020 Placebo 11421011 C4591001 1142 11421011 18-55 30JUL2020 40261 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 11421012 C4591001 1142 11421012 56-85 30JUL2020 220138 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 11421013 C4591001 1142 11421013 56-85 30JUL2020 220601 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 11421014 C4591001 1142 11421014 18-55 30JUL2020 40264 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 11421015 C4591001 1142 11421015 18-55 30JUL2020 40607 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 11421016 C4591001 1142 11421016 18-55 30JUL2020 40610 Placebo 30JUL2020 Placebo 18AUG2020 Placebo 11471001 C4591001 1147 11471001 18-55 30JUL2020 40577 Placebo 30JUL2020 Placebo 21AUG2020 Placebo 090177e194e7a460\Final\Final On: 14-Sep-2020 01:45 (GMT) Page 36 FDA-CBER-2021-5683-0024813 16.1.7.2 Listing of Randomization Scheme and Actual Vaccine Received – Phase 2 Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 a. Subject Study Identifier = the subject study identifier is the current study 4 -digit site number followed by unique 4 -digit subject identifier. PFIZER CONFIDENTIAL SDTM Creation: 05SEP2020 (14:18) Source Data: adsl Table Generation: 10SEP2020 (21:41) (Cutoff Date: 02SEP2020, Snapshot Date: 04SEP2020) Output File: ./nda2_unblinded/C4591001_IA_P2/adsl_l003_p2 090177e194e7a460\Final\Final On: 14-Sep-2020 01:45 (GMT) Page 37 FDA-CBER-2021-5683-0024814 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10011004 C4591001 1001 10011004 18-55 04MAY2020 1084 BNT162b1 (10 μg) 04MAY2020 BNT162b1 (10 μg) 26MAY2020 BNT162b1 (10 μg) 10011005 C4591001 1001 10011005 18-55 06MAY2020 1093 Placebo 06MAY2020 Placebo 26MAY2020 Placebo 10011006 C4591001 1001 10011006 18-55 06MAY2020 1090 BNT162b1 (10 μg) 06MAY2020 BNT162 b1 (10 μg) 27MAY2020 BNT162b1 (10 μg) 10011007 C4591001 1001 10011007 18-55 06MAY2020 1092 BNT162b1 (10 μg) 06MAY2020 BNT162b1 (10 μg) 28MAY2020 BNT162b1 (10 μg) 10011008 C4591001 1001 10011008 18-55 06MAY2020 1094 BNT162b1 (10 μg) 06MAY2020 BNT162b1 (10 μg) 27MAY2020 BNT162b1 (10 μg) 10011009 C4591001 1001 10011009 18-55 06MAY2020 1095 BNT162b1 (10 μg) 06MAY2020 BNT162b1 (10 μg) 27MAY2020 BNT162b1 (10 μg) 10011011 C4591001 1001 10011011 18-55 11MAY2020 1220 BNT162b1 (30 μg) 11MAY2020 BNT162b1 (30 μg) 01JUN2020 BNT162b1 (30 μg) 10011012 C4591001 1001 10011012 18-55 13MAY2020 1230 BNT162b1 (30 μg) 13MAY2020 BNT162b1 (30 μg) 03JUN2020 BNT162b1 (30 μg) 10011013 C4591001 1001 10011013 18-55 18MAY2020 1355 Placebo 18MAY2020 Placebo 17AUG2020 Placebo 100110 15 C4591001 1001 10011015 18-55 11MAY2020 1219 BNT162b1 (30 μg) 11MAY2020 BNT162b1 (30 μg) 01JUN2020 BNT162b1 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 38 FDA-CBER-2021-5683-0024815 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10011017 C4591001 1001 10011017 18-55 13MAY2020 1228 BNT162b1 (30 μg) 13MAY2020 BNT162b1 (30 μg) 03JUN2020 BNT162b1 (30 μg) 10011019 C4591001 1001 10011019 18-55 13MAY2020 1229 BNT162b1 (30 μg) 13MAY2020 BNT162b1 (30 μg) 03JUN2020 BNT162b1 (30 μg) 10011020 C4591001 1001 10011020 18-55 13MAY2020 1226 BNT162b1 (30 μg) 13MAY2020 BNT162b1 (30 μg) 03JUN2020 BNT162b1 (30 μg) 10011021 C4591001 1001 10011021 18-55 20MAY2020 1356 Placebo 20MAY2020 Placebo 17AUG2020 Placebo 10011024 C4591001 1001 10011024 18-55 13MAY2020 1225 BNT162b1 (30 μg) 13MAY2020 BNT162b1 (30 μg) 03JUN2020 BNT162b1 (30 μg) 10011026 C4591001 1001 10011026 18-55 18MAY2020 1354 BNT162b1 (100 μg) 18MAY2020 BNT162b1 (100 μg) 13AUG2020 BNT162b1 (10 μg) 10011028 C4591001 1001 10011028 18-55 20MAY2020 1359 BNT162b1 (100 μg) 20MAY2020 BNT162b1 (100 μg) 17AUG2020 BNT162b1 (10 μg) 10011030 C4591001 1001 10011030 18-55 20MAY2020 1357 BNT162b1 (100 μg) 20MAY2020 BNT162b1 (100 μg) 17AUG2020 BNT162b1 (10 μg) 10011032 C4591001 1001 10011032 18-55 20MAY2020 1360 BNT162b1 (100 μg) 20MAY2020 BNT162b1 (100 μg) 13AUG2020 BNT162b1 (10 μg) 10011034 C4591001 1001 10011034 18-55 20MAY2020 1358 BNT162b1 (100 μg) 20MAY2020 BNT162b1 (100 μg) 17AUG2020 BNT162b1 (10 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 39 FDA-CBER-2021-5683-0024816 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10011037 C4591001 1001 10011037 65-85 11JUN2020 1631 BNT162b1 (10 μg) 11JUN2020 BNT162b1 (10 μg) 30JUN2020 BNT162b1 (10 μg) 10011039 C4591001 1001 10011039 65-85 09JUN2020 1624 BNT162 b1 (10 μg) 09JUN2020 BNT162b1 (10 μg) 29JUN2020 BNT162b1 (10 μg) 10011040 C4591001 1001 10011040 65-85 11JUN2020 1635 BNT162b1 (10 μg) 11JUN2020 BNT162b1 (10 μg) 02JUL2020 BNT162b1 (10 μg) 10011041 C4591001 1001 10011041 65-85 11JUN2020 1632 BNT162b1 (10 μg) 11JUN2020 BNT162b1 (10 μg) 02JUL2020 BNT162b1 (10 μg) 10011042 C4591001 1001 10011042 65-85 11JUN2020 1634 Placebo 11JUN2020 Placebo 30JUN2020 Placebo 10011043 C4591001 1001 10011043 65-85 15JUN2020 2029 BNT162b1 (20 μg) 15JUN2020 BNT162b1 (20 μg) 08JUL2020 BNT162b1 (20 μg) 10011044 C4591001 1001 10011044 65-85 09JUN2020 1625 BNT162b1 (10 μg) 09JUN2020 BNT162b1 (10 μg) 29JUN2020 BNT162b1 (10 μg) 10011045 C4591001 1001 10011045 65-85 11JUN2020 1633 BNT162b1 (10 μg) 11JUN2020 BNT162b1 (10 μg) 02JUL20 20 BNT162b1 (10 μg) 10011046 C4591001 1001 10011046 65-85 18JUN2020 1767 BNT162b1 (30 μg) 18JUN2020 BNT162b1 (30 μg) 09JUL2020 BNT162b1 (30 μg) 10011048 C4591001 1001 10011048 65-85 16JUN2020 1759 BNT162b1 (30 μg) 16JUN2020 BNT162b1 (30 μg) 08JUL2020 BNT 162b1 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 40 FDA-CBER-2021-5683-0024817 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10011049 C4591001 1001 10011049 65-85 15JUN2020 2030 BNT162b1 (20 μg) 15JUN2020 BNT162b1 (20 μg) 06JUL2020 BNT162b1 (20 μg) 10011050 C4591001 1001 10011050 65-85 17JUN2020 2031 BNT162b1 (20 μg) 17JUN2020 BNT162b1 (20 μg) 07JUL2020 BNT162b1 (20 μg) 10011052 C4591001 1001 10011052 65-85 17JUN2020 2037 BNT162b1 (20 μg) 17JUN2020 BNT162b1 (20 μg) 08JUL2020 BNT162b1 (20 μg) 10011053 C4591001 1001 10011053 65-85 16JUN2020 1760 Placebo 16JUN2020 Placebo 09JUL2020 Placebo 10011055 C4591001 1001 10011055 65-85 17JUN2020 2039 BNT162b1 (20 μg) 17JUN2020 BNT162b1 (20 μg) 08JUL2020 BNT162b1 (20 μg) 10011057 C4591001 1001 10011057 65-85 17JUN2020 2038 Placebo 17JUN2020 Placebo 08JUL2020 Placebo 10011058 C4591001 1001 10011058 65-85 18JUN2020 1768 BNT1 62b1 (30 μg) 18JUN2020 BNT162b1 (30 μg) 09JUL2020 BNT162b1 (30 μg) 10011059 C4591001 1001 10011059 65-85 17JUN2020 2040 BNT162b1 (20 μg) 17JUN2020 BNT162b1 (20 μg) 08JUL2020 BNT162b1 (20 μg) 10011061 C4591001 1001 10011061 65-85 18JUN2020 1765 BNT162b1 (30 μg) 18JUN2020 BNT162b1 (30 μg) 09JUL2020 BNT162b1 (30 μg) 10011063 C4591001 1001 10011063 65-85 18JUN2020 1769 BNT162b1 (30 μg) 18JUN2020 BNT162b1 (30 μg) 07JUL2020 BNT162b1 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 41 FDA-CBER-2021-5683-0024818 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10011064 C4591001 1001 10011064 65-85 18JUN2020 1770 Placebo 18JUN202 0 Placebo 07JUL2020 Placebo 10011066 C4591001 1001 10011066 18-55 29JUN2020 1489 Placebo 29JUN2020 Placebo 20JUL2020 Placebo 10011067 C4591001 1001 10011067 18-55 01JUL2020 1499 BNT162b1 (20 μg) 01JUL2020 BNT162b1 (20 μg) 22JUL2020 BNT162b1 (20 μg) 1001 1068 C4591001 1001 10011068 18-55 29JU N2020 1490 BNT162b1 (20 μg) 29JUN2020 BNT162b1 (20 μg) 20JUL2020 BNT162b1 (20 μg) 10011069 C4591001 1001 10011069 18-55 01JUL2020 1496 Placebo 01JUL2020 Placebo 22JUL2020 Placebo 10011070 C4591001 1001 10011070 18-55 01JUL2020 1500 BNT162b1 (20 μg) 01JUL2020 BNT162b1 (20 μg) 22JUL2020 BNT162b1 (20 μg) 10011071 C4591001 1001 10011071 18-55 01JUL2020 1497 BNT162b1 (20 μg) 01JUL2020 BNT162b1 (20 μg) 22JUL2020 BNT162b1 (20 μg) 10011076 C4591001 1001 10011076 18-55 01JUL 2020 1498 BNT162b1 (20 μg) 01JUL2020 BNT162b1 (20 μg) 21JUL2020 BNT162b1 (20 μg) 10011081 C4591001 1001 10011081 >55 28JUL2020 220015 Placebo 28JUL2020 Placebo 18AUG2020 Placebo 10011082 C4591001 1001 10011082 >55 03AUG2020 221589 BNT162b2 (30 μg) 03AUG2 020 BNT162b2 (30 μg) 24AUG2020 BNT162b2 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 42 FDA-CBER-2021-5683-0024819 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10011083 C4591001 1001 10011083 16-55 31JUL2020 40545 BNT162b2 (30 μg) 31JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 10011084 C4591001 1001 10011084 >55 28JUL2020 220026 BNT162b2 (30 μg) 28JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 10011085 C4591001 1001 10011085 16-55 28JUL2020 40018 BNT162b2 (30 μg) 28JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 10011086 C4591001 1001 10011086 16-55 28JUL2020 40021 Placebo 28JUL2020 Placebo 18AUG2 020 Placebo 10011087 C4591001 1001 10011087 16-55 28JUL2020 40032 BNT162b2 (30 μg) 28JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 10011088 C4591001 1001 10011088 16-55 28JUL2020 40047 BNT162b2 (30 μg) 28JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 10011089 C4591001 1001 10011089 16-55 28JUL2020 40070 BNT162b2 (30 μg) 28JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 10011090 C4591001 1001 10011090 >55 29JUL2020 220087 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μ g) 10011091 C4591001 1001 10011091 16-55 29JUL2020 40171 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 10011092 C4591001 1001 10011092 16-55 29JUL2020 40172 Placebo 29JUL2020 Placebo 19AUG2020 Placebo 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 43 FDA-CBER-2021-5683-0024820 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10011093 C4591001 1001 1001 1093 >55 29JUL2020 220088 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 10011094 C4591001 1001 10011094 >55 29JUL2020 220090 Placebo 29JUL2020 Placebo 20AUG2020 Placebo 10011095 C4591001 1001 10011095 16-55 29JUL2020 40178 BNT162 b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 10011096 C4591001 1001 10011096 >55 29JUL2020 220095 Placebo 29JUL2020 Placebo 20AUG2020 Placebo 10011097 C4591001 1001 10011097 >55 30JUL2020 220387 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 21AUG2020 BNT162b2 (30 μg) 10011098 C4591001 1001 10011098 >55 30JUL2020 220393 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 10011099 C4591001 1001 10011099 >55 30JUL2020 220389 Placebo 30JUL2020 Placebo 20AUG2020 Placebo 10011100 C4591001 1001 10011100 >55 30JUL2020 220395 Placebo 30JUL2020 Placebo 18AUG2020 Placebo 10011101 C4591001 1001 10011101 16-55 30JUL2020 40180 Placebo 30JUL2020 Placebo 20AUG2020 Placebo 10011102 C4591001 1001 10011102 16-55 30JUL2020 40541 Place bo 30JUL2020 Placebo 20AUG2020 Placebo 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 44 FDA-CBER-2021-5683-0024821 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10011103 C4591001 1001 10011103 >55 30JUL2020 220625 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 21AUG2020 BNT162b2 (30 μg) 10011104 C4591001 1001 10011104 >55 30JUL2020 220626 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 21AUG2020 BNT162b2 (30 μg) 10011105 C4591001 1001 10011105 16-55 31JUL2020 40547 Place bo 31JUL2020 Placebo 21AUG2020 Placebo 10011106 C4591001 1001 10011106 16-55 31JUL2020 40552 BNT162b2 (30 μg) 31JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 10011107 C4591001 1001 10011107 16-55 31JUL2020 41035 Placebo 31JUL2020 Placebo 21AUG2020 Placebo 10011108 C4591001 1001 10011108 >55 31JUL2020 220631 Placebo 31JUL2020 Placebo 19AUG2020 Placebo 10011109 C4591001 1001 10011109 >55 31JUL2020 221105 BNT162b2 (30 μg) 31JUL2020 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 10011110 C4591001 1001 10011110 >55 31JUL2020 220633 Placebo 31JUL2020 Placebo 21AUG2020 Placebo 10011111 C4591001 1001 10011111 >55 31JUL2020 221108 Placebo 31JUL2020 Placebo 24AUG2020 Placebo 10011112 C4591001 1001 10011112 >55 03AUG2020 221112 BNT162b2 (30 μg) 03AUG2020 BNT1 62b2 (30 μg) 24AUG2020 BNT162b2 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 45 FDA-CBER-2021-5683-0024822 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10011113 C4591001 1001 10011113 16-55 03AUG2020 41039 BNT162b2 (30 μg) 03AUG2020 BNT162b2 (30 μg) 24AUG2020 BNT162b2 (30 μg) 10011114 C4591001 1001 10011114 >55 03AUG2020 221113 Placebo 03AUG2020 Placebo 24AUG2020 Placebo 10011115 C4591001 1001 10011115 >55 03AUG2020 221593 Placebo 03AUG2020 Placebo 25AUG2020 Placebo 10011116 C4591001 1001 10011116 >55 03AUG2020 221595 Placebo 03AUG2020 Placebo 25AUG2020 Placebo 10011117 C4591001 1001 10011117 >55 03AUG2020 22159 6 BNT162b2 (30 μg) 03AUG2020 BNT162b2 (30 μg) 26AUG2020 BNT162b2 (30 μg) 10011118 C4591001 1001 10011118 >55 03AUG2020 221792 BNT162b2 (30 μg) 03AUG2020 BNT162b2 (30 μg) 24AUG2020 BNT162b2 (30 μg) 10011119 C4591001 1001 10011119 >55 03AUG2020 221793 Placeb o 03AUG2020 Placebo 24AUG2020 Placebo 10011120 C4591001 1001 10011120 >55 04AUG2020 221798 Placebo 04AUG2020 Placebo 25AUG2020 Placebo 10011121 C4591001 1001 10011121 >55 04AUG2020 221799 BNT162b2 (30 μg) 04AUG2020 BNT162b2 (30 μg) 25AUG2020 BNT162b2 (30 μg) 10011122 C4591001 1001 10011122 >55 04AUG2020 222235 BNT162b2 (30 μg) 04AUG2020 BNT162b2 (30 μg) 25AUG2020 BNT162b2 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 46 FDA-CBER-2021-5683-0024823 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10011123 C4591001 1001 10011123 >55 04AUG2020 222239 BNT162b2 (30 μg) 04AUG2020 BNT162b2 (30 μg) 25AUG2020 BNT162 b2 (30 μg) 10011124 C4591001 1001 10011124 >55 04AUG2020 222244 Placebo 04AUG2020 Placebo 26AUG2020 Placebo 10011125 C4591001 1001 10011125 16-55 04AUG2020 41040 BNT162b2 (30 μg) 04AUG2020 BNT162b2 (30 μg) 10011126 C4591001 1001 10011126 16-55 04AUG2020 41042 Placebo 04AUG2020 Placebo 24AUG2020 Placebo 10011127 C4591001 1001 10011127 >55 04AUG2020 222243 Placebo 04AUG2020 Placebo 25AUG2020 Placebo 10011129 C4591001 1001 10011129 16-55 05AUG2020 42967 BNT162b2 (30 μg) 05AUG2020 BNT162b2 (30 μg) 24AUG2020 BNT162b 2 (30 μg) 10011130 C4591001 1001 10011130 16-55 05AUG2020 42969 Placebo 05AUG2020 Placebo 26AUG2020 Placebo 10011131 C4591001 1001 10011131 16-55 05AUG2020 42976 BNT162b2 (30 μg) 05AUG2020 BNT162b2 (30 μg) 26AUG2020 BNT162b2 (30 μg) 10011132 C4591001 1001 10011132 16-55 05AUG2020 42973 Placebo 05AUG2020 Placebo 26AUG2020 Placebo 10011133 C4591001 1001 10011133 >55 05AUG2020 222907 BNT162b2 (30 μg) 05AUG2020 BNT162b2 (30 μg) 27AUG2020 BNT162b2 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 47 FDA-CBER-2021-5683-0024824 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10011134 C4591001 1001 10011134 >55 05AUG2020 222906 Placebo 05AUG2020 Placebo 26AUG2020 Placebo 10011135 C4591001 1001 10011135 16-55 05AUG2020 43218 Placebo 05AUG2020 Placebo 24AUG2020 Placebo 10011136 C4591001 1001 10011136 16-55 06AUG2020 43219 BNT162b2 (30 μg) 06AUG2020 BNT162b2 (30 μg) 27AUG2020 BNT 162b2 (30 μg) 10011137 C4591001 1001 10011137 >55 06AUG2020 43221 BNT162b2 (30 μg) 06AUG2020 BNT162b2 (30 μg) 27AUG2020 BNT162b2 (30 μg) 10011138 C4591001 1001 10011138 16-55 06AUG2020 43225 Placebo 06AUG2020 Placebo 27AUG2020 Placebo 10011139 C4591001 1001 10011139 >55 06AUG2020 222908 BNT162b2 (30 μg) 06AUG2020 BNT162b2 (30 μg) 27AUG2020 BNT162b2 (30 μg) 10011141 C4591001 1001 10011141 >55 06AUG2020 222916 Placebo 06AUG2020 Placebo 27AUG2020 Placebo 10011142 C4591001 1001 10011142 >55 06AUG2020 22364 9 Placebo 06AUG2020 Placebo 25AUG2020 Placebo 10011143 C4591001 1001 10011143 16-55 06AUG2020 43877 BNT162b2 (30 μg) 06AUG2020 BNT162b2 (30 μg) 27AUG2020 BNT162b2 (30 μg) 10011144 C4591001 1001 10011144 >55 07AUG2020 223653 Placebo 07AUG2020 Placebo 28AU G2020 Placebo 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 48 FDA-CBER-2021-5683-0024825 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10011145 C4591001 1001 10011145 16-55 07AUG2020 43878 Placebo 07AUG2020 Placebo 28AUG2020 Placebo 10011146 C4591001 1001 10011146 16-55 07AUG2020 43882 Placebo 07AUG2020 Placebo 28AUG2020 Placebo 10011147 C4591001 1001 10011147 >55 07AUG20 20 223655 BNT162b2 (30 μg) 07AUG2020 BNT162b2 (30 μg) 28AUG2020 BNT162b2 (30 μg) 10011148 C4591001 1001 10011148 >55 07AUG2020 223656 BNT162b2 (30 μg) 07AUG2020 BNT162b2 (30 μg) 28AUG2020 BNT162b2 (30 μg) 10011149 C4591001 1001 10011149 16-55 07AUG2020 43887 BNT16 2b2 (30 μg) 07AUG2020 BNT162b2 (30 μg) 28AUG2020 BNT162b2 (30 μg) 10021003 C4591001 1002 10021003 18-55 04MAY2020 1081 BNT162b1 (10 μg) 04MAY2020 BNT162b1 (10 μg) 26MAY2020 BNT162b1 (10 μg) 10021004 C4591001 1002 10021004 18-55 04MAY2020 1082 BNT162b1 (10 μg) 04MAY2020 BNT162b1 (10 μg) 26MAY2020 BNT162b1 (10 μg) 10021005 C4591001 1002 10021005 18-55 04MAY2020 1083 Placebo 04MAY2020 Placebo 26MAY2020 Placebo 10021006 C4591001 1002 10021006 18-55 11MAY2020 1218 BNT162b1 (30 μg) 11MAY2020 BNT162b1 (30 μg) 02JUN2020 BNT162b1 (30 μg) 10021007 C4591001 1002 10021007 18-55 06MAY2020 1089 BNT162b1 (10 μg) 06MAY2020 BNT162b1 (10 μg) 26MAY2020 BNT162b1 (10 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 49 FDA-CBER-2021-5683-0024826 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10021008 C4591001 1002 10021008 18-55 06MAY2020 1088 Placebo 06MAY2020 Placebo 26MAY2020 Placebo 10021 009 C4591001 1002 10021009 18-55 06MAY2020 1091 BNT162b1 (10 μg) 06MAY2020 BNT162b1 (10 μg) 26MAY2020 BNT162b1 (10 μg) 10021011 C4591001 1002 10021011 18-55 06MAY2020 1086 BNT162b1 (10 μg) 06MAY2020 BNT162b1 (10 μg) 26MAY2020 BNT162b1 (10 μg) 10021012 C4591001 1002 10021012 18-55 05MAY2020 1085 BNT162b1 (10 μg) 05MAY2020 BNT162b1 (10 μg) 26MAY2020 BNT162b1 (10 μg) 10021013 C4591001 1002 10021013 18-55 06MAY2020 1087 BNT162b1 (10 μg) 06MAY2020 BNT162b1 (10 μg) 26MAY2020 BNT162b1 (10 μg) 100210 14 C4591001 1002 10021014 18-55 13MAY2020 1224 BNT162b1 (30 μg) 13MAY2020 BNT162b1 (30 μg) 02JUN2020 BNT162b1 (30 μg) 10021015 C4591001 1002 10021015 18-55 11MAY2020 1216 BNT162b1 (30 μg) 11MAY2020 BNT162b1 (30 μg) 02JUN2020 BNT162b1 (30 μg) 10021017 C4591001 1002 10021017 18-55 13MAY2020 1221 BNT162b1 (30 μg) 13MAY2020 BNT162b1 (30 μg) 02JUN2020 BNT162b1 (30 μg) 10021018 C4591001 1002 10021018 18-55 11MAY2020 1217 Placebo 11MAY2020 Placebo 02JUN2020 Placebo 10021020 C4591001 1002 10021020 18-55 13MAY2020 1222 BNT 162b1 (30 μg) 13MAY2020 BNT162b1 (30 μg) 02JUN2020 BNT162b1 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 50 FDA-CBER-2021-5683-0024827 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10021021 C4591001 1002 10021021 18-55 13MAY2020 1223 Placebo 13MAY2020 Placebo 02JUN2020 Placebo 10021022 C4591001 1002 10021022 18-55 13MAY2020 1227 Placebo 13MAY2020 Placebo 02JUN2020 Placebo 10021023 C4591001 1002 10021023 18-55 18MAY2020 1352 BNT162b1 (100 μg) 18MAY2020 BNT162b1 (100 μg) 17AUG2020 BNT162b1 (10 μg) 10021024 C4591001 1002 10021024 18-55 18MAY2020 1353 BNT162b1 (100 μg) 18MAY2020 BNT162b1 (100 μg) 31AUG2020 BNT162b1 (10 μg) 10021027 C4591001 1002 10021027 18-55 18MAY2020 1351 BNT162b1 (100 μg) 18MAY2020 BNT162b1 (100 μg) 17AUG2020 BNT162b1 (10 μg) 10021034 C4591001 1002 10021034 18-55 21MAY2020 1363 BNT162b1 (100 μg) 21MAY2020 BNT162b1 (100 μg) 17AUG2020 BNT162b1 (10 μg) 10021035 C4591001 1002 10021035 18-55 21MAY2020 1361 BNT162b1 (100 μg) 21MAY2020 BNT162b1 (100 μg) 18AUG2020 BNT162b1 (10 μg) 10021036 C4591001 1002 10021036 18-55 21MAY2020 1364 BNT162b1 (100 μg) 21MAY2020 BNT162b1 (100 μg) 18AUG2020 BNT162b1 (10 μg ) 10021038 C4591001 1002 10021038 18-55 21MAY2020 1365 BNT162b1 (100 μg) 21MAY2020 BNT162b1 (100 μg) 17AUG2020 BNT162b1 (10 μg) 10021041 C4591001 1002 10021041 18-55 21MAY2020 1362 Placebo 21MAY2020 Placebo 17AUG2020 Placebo 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 51 FDA-CBER-2021-5683-0024828 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10021042 C4591001 1002 10021 042 65-85 09JUN2020 1623 Placebo 09JUN2020 Placebo 30JUN2020 Placebo 10021043 C4591001 1002 10021043 65-85 09JUN2020 1621 BNT162b1 (10 μg) 09JUN2020 BNT162b1 (10 μg) 30JUN2020 BNT162b1 (10 μg) 10021044 C4591001 1002 10021044 65-85 09JUN2020 1622 BNT162b1 (10 μg) 09JUN2020 BNT162b1 (10 μg) 30JUN2020 BNT162b1 (10 μg) 10021045 C4591001 1002 10021045 65-85 11JUN2020 1629 BNT162b1 (10 μg) 11JUN2020 BNT162b1 (10 μg) 30JUN2020 BNT162b1 (10 μg) 10021047 C4591001 1002 10021047 65-85 11JUN2020 1626 Placebo 11JUN2 020 Placebo 30JUN2020 Placebo 10021049 C4591001 1002 10021049 65-85 11JUN2020 1630 BNT162b1 (10 μg) 11JUN2020 BNT162b1 (10 μg) 30JUN2020 BNT162b1 (10 μg) 10021050 C4591001 1002 10021050 65-85 15JUN2020 2026 Placebo 15JUN2020 Placebo 07JUL2020 Placebo 10021052 C4591001 1002 10021052 65-85 11JUN2020 1628 BNT162b1 (10 μg) 11JUN2020 BNT162b1 (10 μg) 30JUN2020 BNT162 b1 (10 μg) 10021053 C4591001 1002 10021053 65-85 11JUN2020 1627 BNT162b1 (10 μg) 11JUN2020 BNT162b1 (10 μg) 30JUN2020 BNT162b1 (10 μg) 10021054 C4591001 1002 10021054 65-85 15JUN2020 2028 BNT162b1 (20 μg) 15JUN2020 BNT162b1 (20 μg) 07JUL2020 BNT162b1 (20 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 52 FDA-CBER-2021-5683-0024829 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10021059 C4591001 1002 10021059 65-85 15JUN2020 1757 BNT162b1 (30 μg) 15JUN2020 BNT162b1 (30 μg) 07JUL2020 BNT162b1 (30 μg) 10021060 C4591 001 1002 10021060 65-85 15JUN2020 2027 BNT162b1 (20 μg) 15JUN2020 BNT162b1 (20 μg) 07JUL2020 BNT162b1 (20 μg) 10021062 C4591001 1002 10021062 65-85 15JUN2020 1756 BNT162b1 (30 μg) 15JUN2020 BNT162b1 (30 μg) 07JUL2020 BNT162b1 (30 μg) 10021063 C4591001 1002 10021063 65-85 15JUN2020 1758 BNT162b1 (30 μg) 15JUN2020 BNT162b1 (30 μg) 07JUL2020 BNT162b1 (30 μg) 10021064 C4591001 1002 10021064 65-85 17JUN2020 2034 BNT162b1 (20 μg) 17JUN2020 BNT162b1 (20 μg) 08JUL2020 BNT162b1 (20 μg) 10021067 C4591001 1002 10021067 65-85 17JUN2020 2032 BNT162b1 (20 μg) 17JUN2020 BNT162b1 (20 μg) 08JUL2020 BNT162b1 (20 μg) 10021068 C4591001 1002 10021068 65-85 17JUN2020 2035 BNT162b1 (20 μg) 17JUN2020 BNT162b1 (20 μg) 08JUL2020 BNT162b1 (20 μg) 10021069 C4591001 1002 10021069 65-85 18JUN2020 1764 BNT162b1 (30 μg) 18JUN2020 BNT162b1 (30 μg) 08JUL2020 BNT162b1 (30 μg) 10021071 C4591001 1002 10021071 65-85 17JUN2020 2036 BNT162b1 (20 μg) 17JUN2020 BNT162b1 (20 μg) 08JUL2020 BNT162b1 (20 μg) 10021072 C4591001 1002 10021072 65-85 18JUN2020 1761 Placebo 18JUN2020 Placebo 08JUL2020 Placebo 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 53 FDA-CBER-2021-5683-0024830 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10021073 C4591001 1002 10021073 65-85 17JUN2020 2033 Placebo 17JUN2020 Placebo 08JUL2020 Placebo 10021074 C4591001 1002 10021074 65-85 18JUN2020 1762 BNT162b1 (30 μg) 18JUN2020 BNT162b1 (30 μg) 08JUL2020 BNT162b1 (30 μg) 10021075 C4591001 1002 10021075 65-85 18JUN2020 1766 BNT162b1 (30 μg) 18JUN2020 BNT162b1 (30 μg) 08JUL2020 BNT162b1 (30 μg) 10021077 C4591001 1002 10021077 65-85 18JUN2020 1763 BNT162b1 (30 μg) 18JUN2020 BNT162b1 (30 μg) 08JUL20 20 BNT162b1 (30 μg) 10021079 C4591001 1002 10021079 18-55 29JUN2020 1487 BNT162b1 (20 μg) 29JUN2020 BNT162b1 (20 μg) 21JUL2020 BNT162b1 (20 μg) 10021080 C4591001 1002 10021080 18-55 01JUL2020 1491 BNT162b1 (20 μg) 01JUL2020 BNT162b1 (20 μg) 21JUL2020 BNT 162b1 (20 μg) 10021081 C4591001 1002 10021081 18-55 01JUL2020 1492 BNT162b1 (20 μg) 01JUL2020 BNT162b1 (20 μg) 21JUL2020 BNT162b1 (20 μg) 10021082 C4591001 1002 10021082 18-55 01JUL2020 1494 BNT162b1 (20 μg) 01JUL2020 BNT162b1 (20 μg) 21JUL2020 BNT162b1 (20 μg) 10021083 C4591001 1002 10021083 18-55 01JUL2020 1495 Placebo 01JUL2020 Placebo 21JUL2020 Placebo 10021084 C4591001 1002 10021084 18-55 29JUN2020 1488 BNT162b1 (20 μg) 29JUN2020 BNT162b1 (20 μg) 21JUL2020 BNT162b1 (20 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 54 FDA-CBER-2021-5683-0024831 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10021085 C4591001 1002 10021085 18-55 29JUN2020 1486 BNT162b1 (20 μg) 29JUN2020 BNT162b1 (20 μg) 21JUL2020 BNT162b1 (20 μg) 10021087 C4591001 1002 10021087 18-55 01JUL2020 1493 BNT162b1 (20 μg) 01JUL2020 BNT162b1 (20 μg) 21JUL2020 BNT162b1 (20 μg) 10031016 C4591001 1003 1003101 6 18-55 09JUN2020 2164 Placebo 09JUN2020 Placebo 30JUN2020 Placebo 10031017 C4591001 1003 10031017 18-55 11JUN2020 2172 Placebo 11JUN2020 Placebo 02JUL2020 Placebo 10031018 C4591001 1003 10031018 18-55 09JUN2020 2163 BNT162b2 (10 μg) 09JUN2020 BNT162b2 (10 μg) 30JUN2020 BNT162b2 (10 μg) 10031019 C4591001 1003 10031019 18-55 11JUN2020 2170 BNT162b2 (10 μg) 11JUN2020 BNT162b2 (10 μg) 02JUL2020 BNT162b2 (10 μg) 10031020 C4591001 1003 10031020 18-55 11JUN2020 2174 BNT162b2 (10 μg) 11JUN2020 BNT162b2 (10 μg) 02JUL2020 BNT162b2 (10 μg) 10031021 C4591001 1003 10031021 18-55 09JUN2020 2165 BNT162b2 (10 μg) 09JUN2020 BNT162b2 (10 μg) 30JUN2020 BNT162b2 (10 μg) 10031022 C4591001 1003 10031022 18-55 11JUN2020 2171 BNT162b2 (10 μg) 11JUN2020 BNT162b2 (10 μg) 02JUL 2020 BNT162b2 (10 μg) 10031024 C4591001 1003 10031024 18-55 11JUN2020 2173 BNT162b2 (10 μg) 11JUN2020 BNT162b2 (10 μg) 02JUL2020 BNT162b2 (10 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 55 FDA-CBER-2021-5683-0024832 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10031026 C4591001 1003 10031026 18-55 17JUN2020 2573 BNT162b2 (20 μg) 17JUN2020 BNT162b2 (20 μg) 08JUL2020 BNT162b2 (20 μg) 10031027 C4591001 1003 10031027 18-55 15JUN2020 2567 BNT162b2 (20 μg) 15JUN2020 BNT162b2 (20 μg) 06JUL2020 BNT162b2 (20 μg) 10031028 C4591001 1003 10031028 18-55 15JUN2020 2566 BNT162b2 (20 μg) 15JUN2020 BNT162b2 (20 μg) 06JUL2020 BNT162b 2 (20 μg) 10031029 C4591001 1003 10031029 18-55 15JUN2020 2568 Placebo 15JUN2020 Placebo 06JUL2020 Placebo 10031030 C4591001 1003 10031030 18-55 17JUN2020 2575 BNT162b2 (20 μg) 17JUN2020 BNT162b2 (20 μg) 08JUL2020 BNT162b2 (20 μg) 10031031 C4591001 1003 10031031 65-85 15JUN2020 3109 BNT162b2 (20 μg) 15JUN2020 BNT162b2 (20 μg) 06JUL2020 BNT162b2 (20 μg) 10031032 C4591001 1003 10031032 18-55 17JUN2020 2572 BNT162b2 (20 μg) 17JUN2020 BNT162b2 (20 μg) 08JUL2020 BNT162b2 (20 μg) 10031034 C4591001 1003 10031 034 18-55 17JUN2020 2571 Placebo 17JUN2020 Placebo 08JUL2020 Placebo 10031035 C4591001 1003 10031035 65-85 15JUN2020 3108 BNT162b2 (20 μg) 15JUN2020 BNT162b2 (20 μg) 06JUL2 020 BNT162b2 (20 μg) 10031036 C4591001 1003 10031036 65-85 15JUN2020 3110 Placebo 15JUN2020 Placebo 06JUL2020 Placebo 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 56 FDA-CBER-2021-5683-0024833 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10031037 C4591001 1003 10031037 65-85 16JUN2020 2840 BNT162b2 (30 μg) 16JUN2020 BNT162b2 (30 μg) 07JUL2020 BNT162b2 (30 μg) 10031038 C4591001 1003 10031038 18-55 17JUN2020 2574 BNT162b2 (20 μg) 17JUN2020 BNT162b2 (20 μ g) 08JUL2020 BNT162b2 (20 μg) 10031043 C4591001 1003 10031043 65-85 16JUN2020 2838 Placebo 16JUN2020 Placebo 07JUL2020 Placebo 10031046 C4591001 1003 10031046 65-85 18JUN2020 2847 Placebo 18JUN2020 Placebo 09JUL2020 Placebo 10031047 C4591001 1003 100310 47 65-85 16JUN2020 2839 BNT162b2 (30 μg) 16JUN2020 BNT162b2 (30 μg) 07JUL2020 BNT162b2 (30 μg) 10031050 C4591001 1003 10031050 18-55 22JUN2020 2297 Placebo 22JUN2020 Placebo 13JUL2020 Placebo 10031051 C4591001 1003 10031051 65-85 18JUN2020 2848 BNT162b2 (30 μg) 18JUN2020 BNT162b2 (30 μg) 09JUL2020 BNT162b2 (30 μg) 10031053 C4591001 1003 10031053 65-85 17JUN2020 3111 BNT162b2 (20 μg) 17JUN2020 BNT162b2 (20 μg) 08JUL2020 BNT162b2 (20 μg) 10031054 C4591001 1003 10031054 65-85 17JUN2020 3115 BNT162b2 (20 μg ) 17JUN2020 BNT162b2 (20 μg) 08JUL2020 BNT162b2 (20 μg) 10031055 C4591001 1003 10031055 65-85 17JUN2020 3112 BNT162b2 (20 μg) 17JUN2020 BNT162b2 (20 μg) 06JUL2020 BNT162b2 (20 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 57 FDA-CBER-2021-5683-0024834 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10031056 C4591001 1003 10031056 65-85 18JUN2020 2844 Placebo 18JUN2020 Placebo 09JUL2020 Placebo 10031057 C4591001 1003 10031057 18-55 24JUN2020 2301 BNT162b2 (30 μg) 24JUN2020 BNT162b2 (30 μg) 15JUL2020 BNT162b2 (30 μg) 10031058 C4591001 1003 10031058 65-85 18JUN2020 2846 BNT162b2 (30 μg) 18JUN2020 BNT162b2 (30 μg) 09JUL2020 BNT162b2 (30 μg) 10031059 C4591001 1003 10031059 18-55 24JUN2020 2305 BNT162b2 (30 μg) 24JUN2020 BNT162b2 (30 μg) 15JUL2020 BNT162b2 (30 μg) 10031061 C4591001 1003 10031061 18-55 22JUN2020 2298 BNT162b2 (30 μg) 22JUN2020 BNT162b2 (30 μg) 13JUL2020 BNT162 b2 (30 μg) 10031063 C4591001 1003 10031063 65-85 17JUN2020 3113 BNT162b2 (20 μg) 17JUN2020 BNT162b2 (20 μg) 08JUL2020 BNT162b2 (20 μg) 10031065 C4591001 1003 10031065 18-55 24JUN2020 2303 BNT162b2 (30 μg) 24JUN2020 BNT162b2 (30 μg) 15JUL2020 BNT162b2 (30 μg) 10031066 C4591001 1003 10031066 18-55 22JUN2020 2296 BNT162b2 (30 μg) 22JUN2020 BNT162b2 (30 μg) 13JUL2020 BNT162b2 (30 μg) 10031067 C4591001 1003 10031067 65-85 17JUN2020 3114 Placebo 17JUN2020 Placebo 08JUL2020 Placebo 10031069 C4591001 1003 1003 1069 65-85 18JUN2020 2845 BNT162b2 (30 μg) 18JUN2020 BNT162b2 (30 μg) 09JUL2020 BNT162b2 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 58 FDA-CBER-2021-5683-0024835 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10031070 C4591001 1003 10031070 18-55 24JUN2020 2304 Placebo 24JUN2020 Placebo 15JUL2020 Placebo 10031072 C4591001 1003 10031072 18-55 24JUN2020 2302 BNT162b 2 (30 μg) 24JUN2020 BNT162b2 (30 μg) 16JUL2020 BNT162b2 (30 μg) 10031076 C4591001 1003 10031076 65-85 29JUN2020 2702 BNT162b2 (10 μg) 29JUN2020 BNT162b2 (10 μg) 20JUL2020 BNT162b2 (10 μg) 10031077 C4591001 1003 10031077 65-85 01JUL2020 2711 BNT162b2 (10 μg) 01JUL2020 BNT162b2 (10 μg) 22JUL2020 BNT162b2 (10 μg) 10031078 C4591001 1003 10031078 65-85 01JUL2020 2712 BNT162b2 (10 μg) 01JUL2020 BNT162b2 (10 μg) 22JUL2020 BNT162b2 (10 μg) 10031079 C4591001 1003 10031079 65-85 01JUL2020 2715 BNT162b2 (10 μg) 01JUL2020 BNT162b2 (10 μg) 22JUL2020 BNT162b2 (10 μg) 10031080 C4591001 1003 10031080 65-85 29JUN2020 2703 BNT162b2 (10 μg) 29JUN2020 BNT162b2 (10 μg) 20JUL2020 BNT162b2 (10 μg) 10031083 C4591001 1003 10031083 65-85 01JUL2020 2714 Placebo 01JUL2020 Placebo 22JUL2020 Placebo 10031087 C4591001 1003 10031087 65-85 01JUL2020 2713 BNT162b2 (10 μg) 01JUL2020 BNT162b2 (10 μg) 22JUL2020 BNT162b2 (10 μg) 10031088 C4591001 1003 10031088 16-55 27JUL2020 40003 Placebo 27JUL2020 Placebo 17AUG2020 Placebo 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 59 FDA-CBER-2021-5683-0024836 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10031089 C4591001 1003 10031089 >55 27JUL2020 220001 BNT162b2 (30 μg) 27JUL2020 BNT162b2 (30 μg) 17AUG2020 BNT162b2 (30 μg) 10031090 C4591001 1003 10031090 16-55 27JUL2020 40006 BNT162b2 (30 μg) 27JUL2020 BNT162b2 (30 μg) 17AUG2020 BNT162b2 (30 μg) 10031091 C4591001 1003 10031091 >55 27JUL2020 220002 BNT162b2 (30 μg) 27JUL2020 BNT162b2 (30 μg) 17AUG2020 BNT162b2 (30 μg) 10031092 C4591001 1003 10031092 >55 28JUL2020 220005 Placebo 28JUL2020 Placebo 18AUG2020 Placebo 10031093 C4591001 1003 10031093 >55 28JUL2020 2200 11 Placebo 28JUL2020 Placebo 18AUG2020 Placebo 10031094 C4591001 1003 10031094 16-55 28JUL2020 40009 BNT162b2 (30 μg) 28JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 10031095 C4591001 1003 10031095 >55 28JUL2020 220019 BNT162b2 (30 μg) 28JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 10031096 C4591001 1003 10031096 16-55 28JUL2020 40013 BNT162b2 (30 μg) 28JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 10031097 C4591001 1003 10031097 16-55 28JUL2020 40017 Placebo 28JUL2020 Placebo 18AUG20 20 Placebo 10031098 C4591001 1003 10031098 >55 28JUL2020 220023 Placebo 28JUL2020 Placebo 18AUG2020 Placebo 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 60 FDA-CBER-2021-5683-0024837 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10031099 C4591001 1003 10031099 >55 28JUL2020 220037 Placebo 28JUL2020 Placebo 18AUG2020 Placebo 10031100 C4591001 1003 10031100 16-55 28JUL2020 40037 Placebo 28JUL2020 Placebo 18AUG2020 Placebo 10031101 C4591001 1003 10031101 16-55 28JUL2020 40043 Placebo 28JUL2020 Placebo 18AUG2020 Placebo 10031102 C4591001 1003 10031102 >55 28JUL2020 220039 BNT162b2 (30 μg) 28JUL2020 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 10031103 C4591001 1003 10031103 >55 29JUL2020 220124 Placebo 29JUL2020 Placebo 19AUG2020 Placebo 10031104 C4591001 1003 10031104 16-55 29JUL2020 40145 BNT162b2 (30 μg) 29JUL2020 BNT16 2b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 10031105 C4591001 1003 10031105 >55 29JUL2020 220125 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 10031106 C4591001 1003 10031106 >55 29JUL2020 220127 Placebo 29JUL2020 Placebo 19AUG2020 Placebo 10031107 C4591001 1003 10031107 >55 29JUL2020 220132 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 10031108 C4591001 1003 10031108 >55 29JUL2020 220219 BNT162b2 (30 μg) 29JUL2020 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 61 FDA-CBER-2021-5683-0024838 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10031109 C4591001 1003 10031109 >55 30JUL2020 220223 Placebo 30JUL2020 Placebo 20AUG2020 Placebo 10031110 C4591001 1003 10031110 >55 30JUL2020 220225 Placebo 30JUL2020 Placebo 20AUG2020 Placebo 10031111 C4591001 1003 10031111 16-55 30JUL2020 40149 Place bo 30JUL2020 Placebo 20AUG2020 Placebo 10031112 C4591001 1003 10031112 >55 30JUL2020 220226 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 10031113 C4591001 1003 10031113 >55 30JUL2020 220530 Placebo 30JUL2020 Placebo 20AUG2020 Placebo 10031114 C4591001 1003 10031114 >55 30JUL2020 220531 BNT162b2 (30 μg) 30JUL2020 BNT162 b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 10031115 C4591001 1003 10031115 16-55 30JUL2020 40151 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 10031116 C4591001 1003 10031116 16-55 30JUL2020 40153 Placebo 30JUL2020 Placebo 21AUG 2020 Placebo 10031117 C4591001 1003 10031117 >55 30JUL2020 220534 Placebo 30JUL2020 Placebo 20AUG2020 Placebo 10031118 C4591001 1003 10031118 >55 30JUL2020 220540 BNT162b2 (30 μg) 30JUL2020 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 62 FDA-CBER-2021-5683-0024839 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10031119 C4591001 1003 10031119 >55 31JUL2020 220818 Placebo 31JUL2020 Placebo 21AUG2020 Placebo 10031120 C4591001 1003 10031120 >55 31JUL2020 220820 BNT162b2 (30 μg) 31JUL2020 BNT162b2 (30 μg) 21AUG2020 BNT162b2 (30 μg) 10031121 C4591001 1003 10031121 >55 31JUL2020 220821 Place bo 31JUL2020 Placebo 21AUG2020 Placebo 10031122 C4591001 1003 10031122 16-55 31JUL2020 40819 Placebo 31JUL2020 Placebo 21AUG2020 Placebo 10031123 C4591001 1003 10031123 >55 31JUL2020 220826 BNT162b2 (30 μg) 31JUL2020 BNT162b2 (30 μg) 21AUG2020 BNT162b2 (30 μg) 10031124 C4591001 1003 10031124 16-55 31JUL2020 40820 Placebo 31JUL2020 Placebo 21AUG2020 Placebo 10031125 C4591001 1003 10031125 16-55 31JUL2020 40823 BNT162b2 (30 μg) 31JUL2020 BNT162b2 (30 μg) 21AUG2020 BNT162b2 (30 μg) 10031126 C4591001 1003 10031126 >55 31JUL2020 220902 Placebo 31JUL2020 Placebo 21AUG2020 Placebo 10031127 C4591001 1003 10031127 >55 03AUG2020 220906 Placebo 03AUG2020 Placebo 24AUG2020 Placebo 10031128 C4591001 1003 10031128 >55 03AUG2020 220909 BNT162b2 (30 μg) 03AUG2020 BNT 162b2 (30 μg) 24AUG2020 BNT162b2 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 63 FDA-CBER-2021-5683-0024840 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10031129 C4591001 1003 10031129 >55 03AUG2020 220910 BNT162b2 (30 μg) 03AUG2020 BNT162b2 (30 μg) 24AUG2020 BNT162b2 (30 μg) 10031130 C4591001 1003 10031130 >55 03AUG2020 221506 Placebo 03AUG2020 Placebo 24AUG2020 Placebo 10031131 C4591001 1003 10031131 >55 03AUG2020 221507 BNT162b2 (30 μg) 03AUG2020 BNT162b2 (30 μg) 24AUG2020 BNT162b2 (30 μg) 10031132 C4591001 1003 10031132 >55 03AUG2020 221511 Placebo 03AUG2020 Placebo 24AUG2020 Placebo 10031133 C4591001 1003 10031133 >55 03AUG2020 221512 BNT162b2 (30 μg) 03AUG2020 BNT162b2 (30 μg) 24AUG2020 BNT162b2 (30 μg) 10031134 C4591001 1003 10031134 >55 03AUG2020 221671 Placebo 03AUG2020 Placebo 24AUG2020 Placebo 10031135 C4591001 1003 10031135 >55 03AUG2020 221672 BNT1 62b2 (30 μg) 03AUG2020 BNT162b2 (30 μg) 24AUG2020 BNT162b2 (30 μg) 10031136 C4591001 1003 10031136 >55 03AUG2020 221673 BNT162b2 (30 μg) 03AUG2020 BNT162b2 (30 μg) 24AUG2020 BNT162b2 (30 μg) 10031137 C4591001 1003 10031137 16-55 04AUG2020 40828 BNT162b2 (30 μg) 04AUG2020 BNT162b2 (30 μg) 25AUG2020 BNT162b2 (30 μg) 10031138 C4591001 1003 10031138 16-55 04AUG2020 42130 BNT162b2 (30 μg) 04AUG2020 BNT162b2 (30 μg) 25AUG2020 BNT162b2 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 64 FDA-CBER-2021-5683-0024841 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10031139 C4591001 1003 10031139 >55 04AUG2020 221679 Placebo 04AUG2 020 Placebo 26AUG2020 Placebo 10031140 C4591001 1003 10031140 16-55 04AUG2020 42131 Placebo 10031141 C4591001 1003 10031141 16-55 04AUG2020 42133 Placebo 04AUG2020 Placebo 25AUG2020 Placebo 10031142 C4591001 1003 10031142 >55 04AUG2020 222355 Placebo 04AUG2020 Placebo 25AUG2020 Placebo 10031143 C4591001 1003 10031143 16-55 04AUG2020 42136 BNT162b2 (30 μg) 10031144 C4591001 1003 10031144 16-55 04AUG2020 42522 BNT162b2 (30 μg) 04AUG2020 BNT162b2 (30 μg) 25AUG2020 BNT162b2 (30 μg) 10031145 C4591001 1003 10031145 >55 04AUG2020 222356 BNT162b2 (30 μg) 04AUG2020 BNT162b2 (30 μg) 25AUG2020 BNT162b2 (30 μg) 10031146 C4591001 1003 10031146 16-55 05AUG2020 42524 BNT162b2 (30 μg) 05AUG2020 BNT162b2 (30 μg) 25AUG2020 BNT162b2 (30 μg) 10031147 C4591001 1003 10031147 16-55 05AUG2020 42526 Placebo 05AUG2020 Placebo 26AUG2020 Placebo 10031148 C4591001 1003 10031148 >55 05AUG2020 222358 BNT162b2 (30 μg) 05AUG2020 BNT162b2 (30 μg) 26AUG2020 BNT162b2 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 65 FDA-CBER-2021-5683-0024842 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10031149 C4591001 1003 10031149 >55 05AUG2020 222359 Placebo 05AUG2020 Placebo 26AUG2020 Placebo 10031150 C4591001 1003 10031150 >55 05AUG2020 222874 Placebo 05AUG2020 Placebo 26AUG2020 Placebo 10031151 C4591001 1003 10031151 16-55 05AUG2020 42529 Placebo 05AUG2020 Placebo 26AUG2020 Placebo 10031152 C4591001 1003 10031152 >55 05AUG2020 222875 BNT162b2 (30 μg) 05AUG2020 BNT162b2 (30 μg) 26AUG20 20 BNT162b2 (30 μg) 10031153 C4591001 1003 10031153 >55 06AUG2020 222877 BNT162b2 (30 μg) 06AUG2020 BNT162b2 (30 μg) 25AUG2020 BNT162b2 (30 μg) 10031154 C4591001 1003 10031154 >55 06AUG2020 222880 Placebo 06AUG2020 Placebo 27AUG2020 Placebo 10031155 C4591001 1003 10031155 16-55 06AUG2020 43470 Placebo 06AUG2020 Placebo 27AUG2020 Placebo 10031156 C4591001 1003 10031156 16-55 06AUG2020 43474 Placebo 06AUG2020 Placebo 27AUG2020 Placebo 10031157 C4591001 1003 10031157 >55 06AUG2020 223388 Placebo 06AUG2020 Placebo 27AUG2020 Placebo 10031158 C4591001 1003 10031158 16-55 06AUG2020 43479 BNT162b2 (30 μg) 06AUG2020 BNT162b2 (30 μg) 28AUG2020 BNT162b2 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 66 FDA-CBER-2021-5683-0024843 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10031159 C4591001 1003 10031159 >55 06AUG2020 223389 BNT162b2 (30 μg) 06AUG2020 BNT162b2 (30 μg) 27AUG2020 BNT162b2 (30 μg) 10031160 C4591001 1003 10031160 16-55 06AUG2020 43480 BNT16 2b2 (30 μg) 06AUG2020 BNT162b2 (30 μg) 27AUG2020 BNT162b2 (30 μg) 10031161 C4591001 1003 10031161 16-55 07AUG2020 44214 Placebo 07AUG2020 Placebo 28AUG2020 Placebo 10031162 C4591001 1003 10031162 16-55 07AUG2020 44217 BNT162b2 (30 μg) 07AUG2020 BNT162b2 (30 μg) 28AUG2020 BNT162b2 (30 μg) 10031163 C4591001 1003 10031163 >55 07AUG2020 223393 Placebo 07AUG2020 Placebo 28AUG2020 Placebo 10031164 C4591001 1003 10031164 >55 07AUG2020 223396 BNT162b2 (30 μg) 07AUG2020 BNT162b2 (30 μg) 28AUG2020 BNT162b2 (30 μg ) 10031165 C4591001 1003 10031165 >55 07AUG2020 223880 Placebo 07AUG2020 Placebo 28AUG2020 Placebo 10031166 C4591001 1003 10031166 16-55 07AUG2020 44221 BNT162b2 (30 μg) 07AUG2020 BNT162b2 (30 μg) 28AUG2020 BNT162b2 (30 μg) 10031167 C4591001 1003 100311 67 >55 07AUG2020 223886 Placebo 07AUG2020 Placebo 28AUG2020 Placebo 10031168 C4591001 1003 10031168 >55 07AUG2020 223887 BNT162b2 (30 μg) 07AUG2020 BNT162b2 (30 μg) 28AUG2020 BNT162b2 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 67 FDA-CBER-2021-5683-0024844 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10031169 C4591001 1003 10031169 >55 07AUG2020 223888 BNT162b2 (30 μg) 07AUG2020 BNT162b2 (30 μg) 28AUG2020 BNT162b2 (30 μg) 10031170 C4591001 1003 10031170 16-55 10AUG2020 44224 Placebo 10AUG2020 Placebo 31AUG2020 Placebo 10031171 C4591001 1003 10031171 16-55 10AUG2020 45113 BNT162b2 (30 μg) 10AUG2020 BNT162b2 (30 μg) 31AUG2020 BNT162b2 (30 μg) 10031172 C4591001 1003 10031172 >55 10AUG2020 224657 BNT162b2 (30 μg) 10AUG2020 BNT162b2 (30 μg) 31AUG2020 BNT162b2 (30 μg) 10031173 C4591001 1003 10031173 >55 10AUG2020 224660 Placebo 10AUG2020 Placebo 31AUG2020 Placebo 10031174 C4591001 1003 10031174 16-55 10AUG2020 45115 Placebo 10AUG2020 Placebo 31AUG2020 Placebo 10031175 C4591001 1003 10031175 16-55 10AUG2020 45118 Placebo 10AUG2020 Placebo 31AUG2020 Placebo 10031176 C4591001 1003 10031176 >55 10AUG2020 224663 BNT162 b2 (30 μg) 10AUG2020 BNT162b2 (30 μg) 31AUG2020 BNT162b2 (30 μg) 10031177 C4591001 1003 10031177 16-55 10AUG2020 45122 BNT162b2 (30 μg) 10AUG2020 BNT162b2 (30 μg) 31AUG2020 BNT162b2 (30 μg) 10031 178 C4591001 1003 10031178 >55 11AUG2020 224668 Placebo 11AUG2020 Placebo 01SEP2020 Placebo 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 68 FDA-CBER-2021-5683-0024845 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10031179 C4591001 1003 10031179 16-55 11AUG2020 46111 Placebo 11AUG2020 Placebo 01SEP2020 Placebo 10031180 C4591001 1003 10031180 16-55 11AUG2020 46116 BNT162b2 (30 μg) 11AUG2020 BNT162b2 (30 μg) 01SEP2020 BNT162b2 (30 μg ) 10031181 C4591001 1003 10031181 >55 11AUG2020 225593 Placebo 11AUG2020 Placebo 01SEP2020 Placebo 10031182 C4591001 1003 10031182 >55 11AUG2020 225594 BNT162b2 (30 μg) 11AUG2020 BNT162b2 (30 μg) 01SEP2020 BNT162b2 (30 μg) 10031183 C4591001 1003 1003118 3 16-55 11AUG2020 46117 BNT162b2 (30 μg) 11AUG2020 BNT162b2 (30 μg) 01SEP2020 BNT162b2 (30 μg) 10031184 C4591001 1003 10031184 16-55 11AUG2020 46119 Placebo 11AUG2020 Placebo 01SEP2020 Placebo 10031185 C4591001 1003 10031185 >55 11AUG2020 225595 Placebo 11AUG2020 Placebo 01SEP2020 Placebo 10031186 C4591001 1003 10031186 16-55 12AUG2020 47001 Placebo 12AUG2020 Placebo 03SEP2020 Placebo 10031187 C4591001 1003 10031187 16-55 12AUG2020 47003 BNT162b2 (30 μg) 12AUG2020 BNT162b2 (30 μg) 01SEP2020 BNT162b2 (30 μg) 10031188 C4591001 1003 10031188 >55 12AUG2020 225597 BNT162b2 (30 μg) 12AUG2020 BNT162b2 (30 μg) 02SEP2020 BNT162b2 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 69 FDA-CBER-2021-5683-0024846 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10031189 C4591001 1003 10031189 >55 12AUG2020 226409 BNT162b2 (30 μg) 12AUG2020 BNT162b2 (30 μg) 31AUG2020 BNT162b2 (30 μg) 10031190 C4591001 1003 10031190 16-55 12AUG2020 47004 Placebo 12AUG2020 Placebo 01SEP2020 Placebo 10031191 C4591001 1003 10031191 16-55 12AUG2020 47008 BNT162b2 (30 μg) 12AUG2020 BNT162b2 (30 μg) 02SEP2020 BNT162b2 (30 μg) 10031192 C4591001 1003 10031192 >55 12AUG2020 226412 Placebo 12AUG2020 Placebo 01SEP2020 Placebo 10031193 C4591001 1003 10031193 >55 13AUG2020 226413 Placebo 13AUG2020 Placebo 03SEP2020 Placebo 10031194 C4591001 1003 10031194 16-55 13AUG2020 48774 BNT162b2 (30 μg) 13AUG2020 BNT162b2 (30 μg) 03SEP2020 BNT162b2 (30 μg) 10031195 C4591001 1003 10031195 >55 13AUG2020 226417 BNT162b2 (30 μg) 13AUG2020 BNT162b2 (30 μg) 03SEP2020 BNT162b2 (30 μg) 10031196 C4591001 1003 10031196 16-55 13AUG2020 48776 Placebo 13AUG2020 Placebo 03SEP2020 Placeb o 10031197 C4591001 1003 10031197 16-55 13AUG2020 48777 Placebo 13AUG2020 Placebo 03SEP2020 Placebo 10031198 C4591001 1003 10031198 16-55 13AUG2020 48779 BNT162b2 (30 μg) 13AUG2020 BNT162b2 (30 μg) 03SEP2020 BNT162b2 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 70 FDA-CBER-2021-5683-0024847 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10031199 C4591001 1003 10031 199 16-55 13AUG2020 49242 BNT162b2 (30 μg) 13AUG2020 BNT162b2 (30 μg) 03SEP2020 BNT162b2 (30 μg) 10031200 C4591001 1003 10031200 >55 13AUG2020 228161 Placebo 13AUG2020 Placebo 03SEP2020 Placebo 10031201 C4591001 1003 10031201 16-55 13AUG2020 49250 BNT162 b2 (30 μg) 13AUG2020 BNT162b2 (30 μg) 03SEP2020 BNT162b2 (30 μg) 10031202 C4591001 1003 10031202 >55 14AUG2020 228167 Placebo 14AUG2020 Placebo 04SEP2020 Placebo 10031203 C4591001 1003 10031203 16-55 14AUG2020 49251 Placebo 14AUG2020 Placebo 04SEP2020 Placebo 10031204 C4591001 1003 10031204 16-55 14AUG2020 49252 Placebo 14AUG2020 Placebo 04SEP2020 Placebo 10031205 C4591001 1003 10031205 16-55 14AUG2020 49868 Placebo 14AUG2020 Placebo 04SEP2020 Placebo 10031206 C4591001 1003 10031206 16-55 14AUG2020 49870 Placebo 14AUG2020 Placebo 04SEP2020 Placebo 10031207 C4591001 1003 10031207 16-55 14AUG2020 49872 BNT162b2 (30 μg) 14AUG2020 BNT162b2 (30 μg) 04SEP2020 BNT162b2 (30 μg) 10031208 C4591001 1003 10031208 >55 14AUG2020 228168 BNT162b2 (30 μg) 14AUG2020 BNT162b2 (30 μg) 04SEP2020 BNT162b2 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 71 FDA-CBER-2021-5683-0024848 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10031209 C4591001 1003 10031209 >55 14AUG2020 228172 BNT162 b2 (30 μg) 14AUG2020 BNT162b2 (30 μg) 04SEP2020 BNT162b2 (30 μg) 100510 02 C4591001 1005 10051002 16-55 07AUG2020 44385 BNT162b2 (30 μg) 07AUG2020 BNT162b2 (30 μg) 26AUG2020 BNT162b2 (30 μg) 10051003 C4591001 1005 10051003 16-55 07AUG2020 44387 Placebo 07AUG2020 Placebo 30AUG2020 Placebo 10051004 C4591001 1005 10051004 16-55 10AUG2020 44389 BNT162b2 (30 μg) 10AUG2020 BNT162b2 (30 μg) 31AUG2020 BNT162b2 (30 μg) 10051005 C4591001 1005 10051005 >55 10AUG2020 224844 BNT162b2 (30 μg) 10AUG2020 BNT162b2 (30 μg ) 31AUG2020 BNT162b2 (30 μg) 10051006 C4591001 1005 10051006 >55 10AUG2020 224842 Placebo 10AUG2020 Placebo 31AUG2020 Placebo 10051007 C4591001 1005 10051007 16-55 10AUG2020 44392 Placebo 10AUG2020 Placebo 31AUG2020 Placebo 10051008 C4591001 1005 100510 08 16-55 10AUG2020 45368 BNT162b2 (30 μg) 10AUG2020 BNT162b2 (30 μg) 01SEP2020 BNT162b2 (30 μg) 10051009 C4591001 1005 10051009 >55 10AUG2020 224845 Placebo 10AUG2020 Placebo 31AUG2020 Placebo 10051010 C4591001 1005 10051010 >55 10AUG2020 224848 BNT162b2 (30 μg) 10AUG2020 BNT162b2 (30 μg) 01SEP2020 BNT162b2 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 72 FDA-CBER-2021-5683-0024849 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10051011 C4591001 1005 10051011 >55 10AUG2020 225142 Placebo 10AUG2020 Placebo 31AUG2020 Placebo 10051012 C4591001 1005 10051012 >55 10AUG2020 225140 Placebo 10AUG2020 Placebo 31AUG2020 Place bo 10051013 C4591001 1005 10051013 >55 10AUG2020 225143 BNT162b2 (30 μg) 10AUG2020 BNT162b2 (30 μg) 31AUG2020 BNT162b2 (30 μg) 10051014 C4591001 1005 10051014 >55 10AUG2020 225146 BNT162b2 (30 μg) 10AUG2020 BNT162b2 (30 μg) 31AUG2020 BNT162b2 (30 μg) 10051015 C4591001 1005 10051015 16-55 10AUG2020 45372 Placebo 10AUG2020 Placebo 31AUG2020 Placebo 10051016 C4591001 1005 10051016 16-55 11AUG2020 45373 BNT162b2 (30 μg) 11AUG2020 BNT162b2 (30 μg) 31AUG2020 BNT162b2 (30 μg) 10051017 C4591001 1005 10051017 16-55 11AUG2020 45374 Placebo 11AUG2020 Placebo 01SEP2020 Placebo 10051018 C4591001 1005 10051018 >55 11AUG2020 225607 BNT162b2 (30 μg) 11AUG2020 BNT162b2 (30 μg) 31AUG2020 BNT162b2 (30 μg) 10051019 C4591001 1005 10051019 >55 11AUG2020 225608 Placebo 11AU G2020 Placebo 01SEP2020 Placebo 10051020 C4591001 1005 10051020 >55 11AUG2020 225610 Placebo 11AUG2020 Placebo 01SEP2020 Placebo 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 73 FDA-CBER-2021-5683-0024850 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10051021 C4591001 1005 10051021 >55 11AUG2020 225614 BNT162b2 (30 μ g) 11AUG2020 BNT162b2 (30 μg) 31AUG2020 BNT162b2 (30 μg) 10051022 C4591001 1005 10051022 >55 11AUG2020 225774 Placebo 11AUG2020 Placebo 31AUG2020 Placebo 10051023 C4591001 1005 10051023 >55 11AUG2020 225777 BNT162b2 (30 μg) 11AUG2020 BNT162b2 (30 μg) 31AUG2020 BNT162b2 (30 μg) 10051024 C4591001 1005 10051024 16-55 11AUG2020 46639 BNT162b2 (30 μg) 11AUG2020 BNT162b2 (30 μg) 31AUG2020 BNT162b2 (30 μg) 10051025 C4591001 1005 10051025 >55 11AUG2020 225779 BNT162b2 (30 μg) 11AUG2020 BNT162b2 (30 μg) 01SEP2020 BNT162b2 (30 μg) 10051026 C4591001 1005 10051026 16-55 11AUG2020 46641 Placebo 11AUG2020 Placebo 02SEP2020 Placebo 10051027 C4591001 1005 10051027 16-55 11AUG2020 46642 Placebo 11AUG2020 Placebo 31AUG2020 Placebo 10051028 C4591001 1005 10051028 16-55 12AUG2020 47011 Placebo 12AUG2020 Placebo 01SEP2020 Placeb o 10051029 C4591001 1005 10051029 16-55 12AUG2020 46647 BNT162b2 (30 μg) 12AUG2020 BNT162b2 (30 μg) 01SEP2020 BNT162b2 (30 μg) 10051030 C4591001 1005 10051030 16-55 12AUG2020 47015 Placebo 12AUG2020 Placebo 01SEP2020 Placebo 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 74 FDA-CBER-2021-5683-0024851 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10051031 C4591001 1005 10051031 16-55 12AUG2020 47019 BNT162b2 (30 μg) 12AUG2020 BNT1 62b2 (30 μg) 02SEP2020 BNT162b2 (30 μg) 10051032 C4591001 1005 10051032 >55 12AUG2020 225781 Placebo 12AUG2020 Placebo 04SEP2020 Placebo 10051033 C4591001 1005 10051033 >55 12AUG2020 226579 Placebo 12AUG2020 Placebo 31AUG2020 Placebo 10051034 C4591001 1005 10051034 >55 12AUG2020 226582 Placebo 12AUG2020 Placebo 02SEP2020 Placebo 10051035 C4591001 1005 10051035 16-55 12AUG2020 47020 BNT162b2 (30 μg) 12AUG2020 BNT162b2 (30 μg) 02SEP2020 BNT162b2 (30 μg) 10051036 C4591001 1005 10051036 16-55 12AUG2020 47597 BNT162b2 (30 μg) 12AUG2020 BNT162b2 (30 μg) 04SEP2020 BNT162b2 (30 μg) 10051037 C4591001 1005 10051037 >55 12AUG2020 226586 BNT162b2 (30 μg) 12AUG2020 BNT162b2 (30 μg) 31AUG2020 BNT162b2 (30 μg) 10051038 C4591001 1005 10051038 >55 12AUG2020 226587 BNT 162b2 (30 μg) 12AUG2020 BNT162b2 (30 μg) 01SEP2020 BNT162b2 (30 μg) 10051039 C4591001 1005 10051039 >55 12AUG2020 227059 BNT162b2 (30 μg) 12AUG2020 BNT162b2 (30 μg) 02SEP2020 BNT162b2 (30 μg) 10051040 C4591001 1005 10051040 >55 12AUG2020 227061 BNT162b2 (30 μg) 12AUG2 020 BNT162b2 (30 μg) 31AUG2020 BNT162b2 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 75 FDA-CBER-2021-5683-0024852 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10051041 C4591001 1005 10051041 16-55 12AUG2020 47921 BNT162b2 (30 μg) 12AUG2020 BNT162b2 (30 μg) 04SEP2020 BNT162b2 (30 μg) 10051042 C4591001 1005 10051042 >55 12AUG2020 227062 Placebo 12AUG2 020 Placebo 02SEP2020 Placebo 10051043 C4591001 1005 10051043 >55 12AUG2020 227067 Placebo 12AUG2020 Placebo 31AUG2020 Placebo 10051044 C4591001 1005 10051044 >55 13AUG2020 227506 Placebo 13AUG2020 Placebo 04SEP2020 Placebo 10051045 C4591001 1005 100510 45 >55 13AUG2020 227504 BNT162b2 (30 μg) 13AUG2020 BNT162b2 (30 μg) 02SEP2020 BNT162b2 (30 μg) 10051046 C4591001 1005 10051046 >55 13AUG2020 227510 Placebo 13AUG2020 Placebo 02SEP2020 Placebo 10051047 C4591001 1005 10051047 >55 13AUG2020 227512 BNT162b2 (30 μg) 13AUG2020 BNT162 b2 (30 μg) 01SEP2020 BNT162b2 (30 μg) 10051048 C4591001 1005 10051048 16-55 13AUG2020 47924 Placebo 13AUG2020 Placebo 02SEP2020 Placebo 10051049 C4591001 1005 10051049 >55 13AUG2020 227670 Placebo 13AUG2020 Placebo 01SEP2020 Placebo 10051050 C4591001 1005 10051050 >55 13AUG2020 227669 BNT162b2 (30 μg) 13AUG2020 BNT162b2 (30 μg) 02SEP2020 BNT162b2 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 76 FDA-CBER-2021-5683-0024853 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10051051 C4591001 1005 10051051 16-55 13AUG2020 47932 BNT162b2 (30 μg) 13AUG2020 BNT162b2 (30 μg) 01SEP2020 BNT162b2 (30 μg) 10051052 C4591001 1005 10051052 16-55 13AUG2020 47929 Placebo 13AUG2020 Placebo 02SEP2020 Placebo 10051053 C4591001 1005 10051053 >55 13AUG2020 227677 BNT162b2 (30 μg) 13AUG2020 BNT162b2 (30 μg) 02SEP2020 BNT162b2 (30 μg) 10051054 C4591001 1005 10051054 16-55 13AUG2020 48727 BNT 162b2 (30 μg) 13AUG2020 BNT162b2 (30 μg) 04SEP2020 BNT162b2 (30 μg) 10051055 C4591001 1005 10051055 16-55 13AUG2020 48728 Placebo 13AUG2020 Placebo 01SEP2020 Placebo 10051056 C4591001 1005 10051056 >55 13AUG2020 227678 Placebo 13AUG2020 Placebo 01SEP2020 Placebo 10051057 C4591001 1005 10051057 16-55 13AUG2020 48729 Placebo 13AUG2020 Placebo 02SEP2020 Placebo 10051058 C4591001 1005 10051058 >55 13AUG2020 228066 Placebo 13AUG2020 Placebo 01SEP2020 Placebo 10051059 C4591001 1005 10051059 16-55 13AUG2020 48733 BNT162b2 (30 μg) 13AUG2020 BNT162b2 (30 μg) 02SEP2020 BNT162b2 (30 μg) 10051060 C4591001 1005 10051060 >55 13AUG2020 228067 BNT162b2 (30 μg) 13AUG2020 BNT162b2 (30 μg) 02SEP2020 BNT162b2 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 77 FDA-CBER-2021-5683-0024854 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10051061 C4591001 1005 10051061 >55 13AUG2020 228076 Placeb o 13AUG2020 Placebo 08SEP2020 Placebo 10051062 C4591001 1005 10051062 >55 13AUG2020 228068 BNT162b2 (30 μg) 13AUG2020 BNT162b2 (30 μg) 02SEP2020 BNT162b2 (30 μg) 10051063 C4591001 1005 10051063 >55 13AUG2020 228248 BNT162b2 (30 μg) 13AUG2020 BNT162b2 (30 μg) 01SEP2020 BNT162b2 (30 μg) 10051064 C4591001 1005 10051064 >55 13AUG2020 228247 Placebo 13AUG2020 Placebo 01SEP2020 Placebo 10051065 C4591001 1005 10051065 >55 13AUG2020 228249 Placebo 13AUG2020 Placebo 02SEP2020 Placebo 10051066 C4591001 1005 1005 1066 16-55 13AUG2020 49457 BNT162b2 (30 μg) 13AUG2020 BNT162b2 (30 μg) 02SEP2020 BNT162b2 (30 μg) 10051067 C4591001 1005 10051067 16-55 13AUG2020 49463 BNT162b2 (30 μg) 13AUG2020 BNT162b2 (30 μg) 01SEP2020 BNT162b2 (30 μg) 10051068 C4591001 1005 10051068 >55 14AUG2020 228255 BNT162b2 (30 μg) 14AUG2020 BNT162b2 (30 μg) 04SEP2020 BNT162b2 (30 μg) 10051069 C4591001 1005 10051069 >55 14AUG2020 228557 Placebo 14AUG2020 Placebo 02SEP2020 Placebo 10051070 C4591001 1005 10051070 16-55 14AUG2020 49464 Placebo 14AUG2020 Placebo 02SEP2020 Placebo 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 78 FDA-CBER-2021-5683-0024855 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10051071 C4591001 1005 10051071 16-55 14AUG2020 49468 Placebo 14AUG2020 Placebo 04SEP2020 Placebo 10051072 C4591001 1005 10051072 >55 14AUG2020 228558 Placebo 14AUG2020 Placebo 03SEP2020 Placebo 10051073 C4591001 1005 10051073 16-55 14AUG2020 49998 Placebo 14AUG2020 Placebo 04SEP2020 Placebo 10051074 C4591001 1005 10051074 >55 14AUG2020 228564 BNT162b2 (30 μg) 14AUG2020 BNT162b2 (30 μg) 02SEP2020 BNT162b2 (30 μg) 10051075 C4591001 1005 10051075 16-55 14AUG2020 50002 Placebo 14AUG2020 Placebo 04SEP2020 Placebo 10051076 C4591001 1005 10051076 16-55 17AUG2020 50006 BNT162b2 (30 μg) 17AUG2020 BNT1 62b2 (30 μg) 09SEP2020 BNT162b2 (30 μg) 10051077 C4591001 1005 10051077 16-55 17AUG2020 50008 BNT162b2 (30 μg) 17AUG2020 BNT162b2 (30 μg) 09SEP2020 BNT162b2 (30 μg) 10051078 C4591001 1005 10051078 >55 19AUG2020 228567 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 09SEP2020 BNT162b2 (30 μg) 10051079 C4591 001 1005 10051079 16-55 19AUG2020 55901 Placebo 19AUG2020 Placebo 09SEP2020 Placebo 10051080 C4591001 1005 10051080 >55 19AUG2020 233154 Placebo 19AUG2020 Placebo 09SEP2020 Placebo 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 79 FDA-CBER-2021-5683-0024856 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10051081 C4591001 1005 10051081 16-55 19AUG2020 55904 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 10SEP2020 BNT162b2 (30 μg) 10051082 C4591001 1005 10051082 16-55 19AUG2020 55905 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 09SEP2020 BNT162b2 (30 μg) 10051083 C4591001 1005 1005 1083 >55 19AUG2020 233159 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 09SEP2020 BNT162b2 (30 μg) 10051084 C4591001 1005 10051084 16-55 19AUG2020 55912 Placebo 19AUG2020 Placebo 09SEP2020 Placebo 10051085 C4591001 1005 10051085 16-55 19AUG2020 57222 Place bo 19AUG2020 Placebo 09SEP2020 Placebo 10051086 C4591001 1005 10051086 >55 20AUG2020 233161 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 08SEP2020 BNT162b2 (30 μg) 10051087 C4591001 1005 10051087 16-55 20AUG2020 57224 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 09SEP2020 BNT162b2 (30 μg) 10051088 C4591001 1005 10051088 >55 20AUG2020 234438 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 10SEP2020 BNT162b2 (30 μg) 10051089 C4591001 1005 10051089 >55 20AUG2020 233164 Placebo 20AUG2020 Placebo 09SEP2020 Placebo 10051090 C4591001 1005 10051090 >55 20AUG2020 234443 Placebo 20AUG2020 Placebo 09SEP2020 Placebo 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 80 FDA-CBER-2021-5683-0024857 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10051091 C4591001 1005 10051091 >55 20AUG2020 234444 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 08SEP2020 BNT162b2 (30 μg) 10051092 C4591001 1005 10051092 >55 20AUG2020 234448 Placebo 20AUG2020 Placebo 09SEP2020 Placebo 10051093 C4591001 1005 10051093 16-55 20AUG2020 57225 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 10SEP2020 BNT162b2 (30 μg) 10051094 C4591001 1005 10051094 16-55 20AUG2020 57229 Placebo 20AUG2020 Placebo 10SEP2020 Placebo 10051095 C4591001 1005 10051095 >55 20AUG2020 234745 Placebo 20AUG2020 Placebo 09SEP2020 Placebo 10051096 C4591001 1005 10051096 >55 20AUG2020 234746 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 08SEP2020 BNT162b2 (30 μg ) 10051097 C4591001 1005 10051097 >55 20AUG2020 234747 Placebo 20AUG2020 Placebo 10SEP2020 Placebo 10051098 C4591001 1005 10051098 >55 20AUG2020 234748 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 09SEP2020 BNT162b2 (30 μg) 10051100 C4591001 1005 1005110 0 16-55 20AUG2020 59217 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 09SEP2020 BNT162b2 (30 μg) 10051101 C4591001 1005 10051101 16-55 20AUG2020 59214 Placebo 20AUG2020 Placebo 08SEP2020 Placebo 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 81 FDA-CBER-2021-5683-0024858 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10051102 C4591001 1005 10051102 >55 20AUG2020 235415 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 10SEP2020 BNT162b2 (30 μg) 10051103 C4591001 1005 10051103 >55 20AUG2020 235416 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 09SEP2020 BNT162b2 (30 μg) 10051104 C4591001 1005 10051104 >55 20AUG2020 59219 BNT162b2 (30 μg ) 20AUG2020 BNT162b2 (30 μg) 10SEP2020 BNT162b2 (30 μg) 10051105 C4591001 1005 10051105 16-55 21AUG2020 59220 Placebo 21AUG2020 Placebo 10SEP2020 Placebo 10051106 C4591001 1005 10051106 16-55 21AUG2020 60019 BNT162b2 (30 μg) 21AUG2020 BNT162b2 (30 μg) 11SEP2020 BNT162b2 (30 μg) 10051107 C4591001 1005 10051107 16-55 21AUG2020 60025 BNT162b2 (30 μg) 21AUG2020 BNT162b2 (30 μg) 10SEP2020 BNT162b2 (30 μg) 10051108 C4591001 1005 10051108 16-55 21AUG2020 60024 Placebo 21AUG2020 Placebo 11SEP2020 Placebo 10051 109 C4591001 1005 10051109 >55 21AUG2020 235417 Placebo 21AUG2020 Placebo 10SEP2020 Placebo 10051111 C4591001 1005 10051111 >55 21AUG2020 235419 Placebo 21AUG2020 Placebo 10SEP2020 Placebo 10051114 C4591001 1005 10051114 >55 21AUG2020 236052 BNT162b2 (30 μg) 21AUG2020 BNT162b2 (30 μg) 11SEP2020 BNT162b2 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 82 FDA-CBER-2021-5683-0024859 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10051115 C4591001 1005 10051115 16-55 21AUG2020 60026 Placebo 21AUG2020 Placebo 09SEP2020 Placebo 10051116 C4591001 1005 10051116 >55 21AUG2020 236053 BNT162b2 (30 μg) 21AUG2020 BNT162b2 (30 μg) 10SEP2020 BNT162b2 (30 μg) 10051117 C4591001 1005 10051117 16-55 21AUG2020 60516 Placebo 21AUG2020 Placebo 11SEP2020 Placebo 10051118 C4591001 1005 10051118 16-55 21AUG2020 60510 Placebo 21AUG2020 Placebo 10SEP2020 Placebo 10051119 C4591001 1005 1005111 9 16-55 24AUG2020 60517 BNT162b2 (30 μg) 24AUG2020 BNT162b2 (30 μg) 14SEP2020 BNT162b2 (30 μg) 10051120 C4591001 1005 10051120 >55 24AUG2020 236055 Placebo 24AUG2020 Placebo 14SEP2020 Placebo 10051121 C4591001 1005 10051121 >55 24AUG2020 236056 Placebo 24AUG2020 Placebo 14SEP2020 Placebo 10051122 C4591001 1005 10051122 >55 24AUG2020 237835 Placebo 24AUG2020 Placebo 14SEP2020 Placebo 10051123 C4591001 1005 10051123 16-55 24AUG2020 60518 BNT162b2 (30 μg) 24AUG2020 BNT162b2 (30 μg) 14SEP2020 BNT162b2 (30 μ g) 10051124 C4591001 1005 10051124 >55 24AUG2020 237838 BNT162b2 (30 μg) 24AUG2020 BNT162b2 (30 μg) 16SEP2020 BNT162b2 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 83 FDA-CBER-2021-5683-0024860 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10051125 C4591001 1005 10051125 16-55 24AUG2020 63763 BNT162b2 (30 μg) 24AUG2020 BNT162b2 (30 μg) 16SEP2020 BNT162b2 (30 μg) 10051126 C4591001 1005 10051126 >55 24AUG 2020 237839 Placebo 24AUG2020 Placebo 14SEP2020 Placebo 10051127 C4591001 1005 10051127 >55 24AUG2020 237840 BNT162b2 (30 μg) 24AUG2020 BNT162b2 (30 μg) 16SEP2020 BNT162b2 (30 μg) 10051128 C4591001 1005 10051128 >55 24AUG2020 238531 Placebo 24AUG2020 Placebo 16SEP2020 Placebo 10051129 C4591001 1005 10051129 16-55 24AUG2020 63766 BNT162b2 (30 μg) 24AUG2020 BNT162b2 (30 μg) 15SEP2020 BNT162b2 (30 μg) 10051130 C4591001 1005 10051130 >55 24AUG2020 238538 BNT162b2 (30 μg) 24AUG2020 BNT162b2 (30 μg) 16SEP2020 BNT162b2 (30 μg) 10051131 C4591001 1005 10051131 >55 24AUG2020 238540 Placebo 24AUG2020 Placebo 16SEP2020 Placebo 10051132 C4591001 1005 10051132 >55 24AUG2020 238539 BNT162b2 (30 μg) 24AUG2020 BNT162b2 (30 μg) 15SEP2020 BNT162b2 (30 μg) 10051134 C4591001 1005 10051134 16-55 24AUG2020 63769 Placebo 24AUG2020 Placebo 15SEP2020 Placebo 10051135 C4591001 1005 10051135 16-55 24AUG2020 63772 Placebo 24AUG2020 Placebo 16SEP2020 Placebo 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 84 FDA-CBER-2021-5683-0024861 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10051136 C4591001 1005 10051136 >55 25AUG2020 239285 BNT162b2 (30 μg) 25AUG2020 BNT162b2 (30 μg) 15SEP2020 BNT162b2 (30 μg) 10051137 C4591001 1005 10051137 >55 16SEP2020 251644 BNT162b2 (30 μg) 16SEP2020 BNT162b2 (30 μg) 05OCT2020 BNT162b2 (30 μg) 10051138 C4591001 1005 10051138 >55 25AUG2020 239286 BNT162b2 (30 μg) 25AUG2020 BNT162b2 (30 μg) 16SEP2020 BNT162b2 (30 μg) 10051139 C4591001 1005 10051139 >55 25AUG2020 239288 Placebo 25AUG2020 Placebo 17SEP2020 Placebo 10051141 C4591001 1005 10051141 >55 25AUG2020 239291 Placebo 25AUG2020 Placebo 15SEP2020 Placebo 10051142 C4591001 1005 10051142 16-55 25AUG2020 65566 Placebo 25AUG2020 Placebo 14SEP2020 Placebo 10051143 C4591001 1005 10051143 >55 25AUG2020 239969 BNT162b2 (30 μg) 25AUG2020 BNT162b2 (30 μg) 16SEP2020 BNT162b2 (30 μg) 10051 144 C4591001 1005 10051144 16-55 25AUG2020 65570 Placebo 25AUG2020 Placebo 15SEP2020 Placebo 10051145 C4591001 1005 10051145 16-55 25AUG2020 65572 BNT162b2 (30 μg) 25AUG2020 BNT162b2 (30 μg) 14SEP2020 BNT162b2 (30 μg) 10051146 C4591001 1005 10051146 16-55 25AUG2020 65571 BNT162b2 (30 μg) 25AUG2020 BNT162b2 (30 μg) 14SEP2020 BNT162b2 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 85 FDA-CBER-2021-5683-0024862 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10051147 C4591001 1005 10051147 16-55 25AUG2020 66642 Placebo 25AUG2020 Placebo 17SEP2020 Placebo 10051148 C4591001 1005 10051148 16-55 25AUG2020 66646 BNT162b2 (30 μg) 25AUG2020 BNT162b2 (30 μg) 16SEP2020 BNT162b2 (30 μg) 10051149 C4591001 1005 10051149 >55 26AUG2020 239971 Placebo 26AUG2020 Placebo 17SEP2020 Placebo 10051150 C4591001 1005 10051150 16-55 26AUG2020 66647 Placebo 26AUG2020 Placebo 14SEP2020 Placebo 10051151 C4591001 1005 10051151 16-55 26AUG2020 66652 BNT162b2 (30 μg) 26AUG2020 BNT162b2 (30 μg) 14SEP2020 BNT162b2 (30 μg) 10051152 C4591001 1005 10051152 >55 26AUG2020 239973 BNT162b2 (30 μg) 26AUG2020 BNT162b2 (30 μg) 18SEP2020 BNT162b2 (30 μg) 10051 153 C4591001 1005 10051153 16-55 26AUG2020 67421 Placebo 26AUG2020 Placebo 17SEP2020 Placebo 10051154 C4591001 1005 10051154 >55 26AUG2020 239980 Placebo 26AUG2020 Placebo 16SEP2020 Placebo 10051155 C4591001 1005 10051155 >55 26AUG2020 241136 Placebo 26AUG2020 Placebo 16SEP2020 Placebo 10051156 C4591001 1005 10051156 >55 26AUG2020 241138 BNT162b2 (30 μ g) 26AUG2020 BNT162b2 (30 μg) 16SEP2020 BNT162b2 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 86 FDA-CBER-2021-5683-0024863 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10051157 C4591001 1005 10051157 >55 26AUG2020 241142 Placebo 26AUG2020 Placebo 16SEP2020 Placebo 10051158 C4591001 1005 10051158 >55 26AUG2020 241143 BNT162b2 (30 μg) 26AUG2020 BNT162 b2 (30 μg) 16SEP2020 BNT162b2 (30 μg) 10051159 C4591001 1005 10051159 >55 26AUG2020 241649 Placebo 26AUG2020 Placebo 16SEP2020 Placebo 10051160 C4591001 1005 10051160 >55 26AUG2020 241653 BNT162b2 (30 μg) 26AUG2020 BNT162b2 (30 μg) 16SEP2020 BNT162b2 (30 μg) 10051161 C4591001 1005 10051161 16-55 26AUG2020 67422 BNT162b2 (30 μg) 26AUG2020 BNT162b2 (30 μg) 17SEP2020 BNT162b2 (30 μg) 10051162 C4591001 1005 10051162 >55 26AUG2020 241656 BNT162b2 (30 μg) 26AUG2020 BNT162b2 (30 μg) 16SEP2020 BNT162b2 (30 μg) 10051163 C4591001 1005 10051163 >55 26AUG2020 241657 Placebo 26AUG2020 Placebo 16SEP2020 Placebo 10051164 C4591001 1005 10051164 16-55 26AUG2020 67425 Placebo 26AUG2020 Placebo 30SEP2020 Placebo 10051165 C4591001 1005 10051165 16-55 26AUG2020 67427 BNT1 62b2 (30 μg) 26AUG2020 BNT162b2 (30 μg) 17SEP2020 BNT162b2 (30 μg) 10051166 C4591001 1005 10051166 16-55 26AUG2020 68664 Placebo 26AUG2020 Placebo 15SEP2020 Placebo 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 87 FDA-CBER-2021-5683-0024864 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10051167 C4591001 1005 10051167 16-55 26AUG2020 68665 BNT162b2 (30 μg) 26AUG2020 BNT162b2 (30 μg) 16SEP2020 BNT162b2 (30 μg) 10051168 C4591001 1005 10051168 16-55 27AUG2020 68666 BNT162b2 (30 μg) 27AUG2020 BNT162b2 (30 μg) 17SEP2020 BNT162b2 (30 μg) 10051169 C4591001 1005 10051169 16-55 27AUG2020 68668 Placebo 27AUG2020 Placebo 17SEP2020 Placebo 10051170 C4591001 1005 10051170 16-55 27AUG2020 69678 Placebo 27AUG2020 Placebo 17SEP2020 Placebo 10051171 C4591001 1005 10051171 16-55 27AUG2020 69684 BNT162b2 (30 μg) 27AUG2020 BNT162b2 (30 μg) 15SEP2020 BNT162b2 (30 μg) 10051172 C4591001 1005 10051172 >55 27AUG2020 242861 Placebo 27AUG2020 Placebo 28SEP2020 Placebo 10051173 C4591001 1005 10051173 >55 27AUG2020 242864 BNT162b2 (30 μg) 27AUG2020 BNT162b2 (30 μg) 17SEP2020 BNT162b2 (30 μg) 10051174 C4591001 1005 10051174 >55 27AUG2020 242867 BNT16 2b2 (30 μg) 27AUG2020 BNT162b2 (30 μg) 17SEP2020 BNT162b2 (30 μg) 10051175 C4591001 1005 10051175 16-55 27AUG2020 69686 Placebo 27AUG2020 Placebo 17SEP2020 Placebo 10051176 C4591001 1005 10051176 >55 27AUG2020 242868 Placebo 27AUG2020 Placebo 15SEP2020 Placebo 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 88 FDA-CBER-2021-5683-0024865 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10051177 C4591001 1005 10051177 >55 27AUG2020 243461 BNT162b2 (30 μg) 27AUG2020 BNT162b2 (30 μg) 16SEP2020 BNT162b2 (30 μg) 10051178 C4591001 1005 10051178 16-55 28AUG2020 69688 BNT162b2 (30 μg) 28AUG2020 BNT162b2 (30 μg) 18SEP2020 BNT162b2 (30 μg ) 10051179 C4591001 1005 10051179 16-55 28AUG2020 71693 Placebo 28AUG2020 Placebo 17SEP2020 Placebo 10051180 C4591001 1005 10051180 >55 28AUG2020 243463 Placebo 28AUG2020 Placebo 17SEP2020 Placebo 10051181 C4591001 1005 10051181 16-55 28AUG2020 71695 BNT162b2 (30 μg) 28AUG2020 BNT162b2 (30 μg) 18SEP2020 BNT162b2 (30 μg) 10051182 C4591001 1005 10051182 16-55 28AUG2020 71703 Placebo 28AUG2020 Placebo 18SEP2020 Placebo 10051183 C4591001 1005 10051183 16-55 31AUG2020 71704 BNT162b2 (30 μg) 31AUG2020 BNT162 b2 (30 μg) 23SEP2020 BNT162b2 (30 μg) 10051184 C4591001 1005 10051184 >55 31AUG2020 243468 Placebo 31AUG2020 Placebo 21SEP2020 Placebo 10051185 C4591001 1005 10051185 >55 31AUG2020 243471 BNT162b2 (30 μg) 31AUG2020 BNT162b2 (30 μg) 21SEP2020 BNT162b2 (30 μg) 10051186 C4591001 1005 10051186 >55 31AUG2020 247473 Placebo 31AUG2020 Placebo 21SEP2020 Placebo 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 89 FDA-CBER-2021-5683-0024866 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10051187 C4591001 1005 10051187 16-55 31AUG2020 76003 Placebo 31AUG2020 Placebo 21SEP2020 Placebo 10051188 C4591001 1005 10051188 16-55 01SEP2020 76004 BNT162b2 (30 μg) 01SEP2020 BNT162b2 (30 μg) 24SEP2020 BNT162b2 (30 μg) 10051189 C4591001 1005 10051189 16-55 01SEP2020 76005 Placebo 01SEP2020 Placebo 22SEP2020 Placebo 10051191 C4591001 1005 10051191 >55 02SEP2020 247475 BNT162b2 (30 μg) 02SEP2020 BNT1 62b2 (30 μg) 21SEP2020 BNT162b2 (30 μg) 10051192 C4591001 1005 10051192 16-55 02SEP2020 76009 BNT162b2 (30 μg) 02SEP2020 BNT162b2 (30 μg) 23SEP2020 BNT162b2 (30 μg) 10051193 C4591001 1005 10051193 >55 02SEP2020 247476 Placebo 02SEP2020 Placebo 21SEP2020 Placebo 10051194 C4591001 1005 10051194 >55 02SEP2020 247479 BNT162b2 (30 μg) 02SEP2020 BNT162b2 (30 μg) 23SEP2020 BNT162b2 (30 μg) 10051195 C4591001 1005 10051195 >55 02SEP2020 250337 BNT162b2 (30 μg) 02SEP2020 BNT162b2 (30 μg) 24SEP2020 BNT162b2 (30 μg ) 10051196 C4591001 1005 10051196 >55 02SEP2020 250340 Placebo 02SEP2020 Placebo 25SEP2020 Placebo 10051197 C4591001 1005 10051197 >55 03SEP2020 250342 Placebo 03SEP2020 Placebo 25SEP2020 Placebo 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 90 FDA-CBER-2021-5683-0024867 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10051198 C4591001 1005 10051198 16-55 03SEP2020 79548 Placebo 03SEP2020 Placebo 25SEP2020 Placebo 10051199 C4591001 1005 10051199 16-55 03SEP2020 79545 BNT162b2 (30 μg) 03SEP2020 BNT162b2 (30 μg) 24SEP2020 BNT162b2 (30 μg) 10051200 C4591001 1005 10051200 16-55 03SEP2020 79549 Placebo 03SEP2020 Placebo 23SEP202 0 Placebo 10051201 C4591001 1005 10051201 >55 03SEP2020 250347 BNT162b2 (30 μg) 03SEP2020 BNT16 2b2 (30 μg) 22SEP2020 BNT162b2 (30 μg) 10051202 C4591001 1005 10051202 >55 03SEP2020 251010 BNT162b2 (30 μg) 03SEP2020 BNT162b2 (30 μg) 24SEP2020 BNT162b2 (30 μg) 10051203 C4591001 1005 10051203 16-55 03SEP2020 79551 BNT162b2 (30 μg) 03SEP2020 BNT162b2 (30 μg) 22SEP2020 BNT162b2 (30 μg) 10051204 C4591001 1005 10051204 >55 03SEP2020 251011 BNT162b2 (30 μg) 03SEP2020 BNT162b2 (30 μg) 22SEP2020 BNT162b2 (30 μg) 10051205 C4591001 1005 10051205 >55 03SEP2020 251225 BNT162b2 (30 μg) 03SEP2020 BNT162b2 (30 μg) 24SEP2020 BNT162b2 (30 μg) 10051206 C4591001 1005 10051206 >55 03SEP2020 251015 Placebo 03SEP2020 Placebo 24SEP2020 Placebo 10051207 C4591001 1005 10051207 >55 03SEP2020 251018 Placebo 03SEP2020 Placebo 23SEP2020 Placebo 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 91 FDA-CBER-2021-5683-0024868 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10051208 C4591001 1005 10051208 >55 03SEP2020 251229 BNT162b2 (30 μg) 03SEP2020 BNT162b2 (30 μg) 25SEP2020 BNT162b2 (30 μg) 10051209 C4591001 1005 10051209 >55 03SEP2020 251227 Placebo 03SEP 2020 Placebo 23SEP2020 Placebo 10051210 C4591001 1005 10051210 16-55 03SEP2020 79914 Placebo 03SEP2020 Placebo 22SEP2020 Placebo 10051211 C4591001 1005 10051211 >55 03SEP2020 251230 Placebo 03SEP2020 Placebo 25SEP2020 Placebo 10051212 C4591001 1005 1005 1212 16-55 03SEP2020 79915 BNT162b2 (30 μg) 03SEP2020 BNT162b2 (30 μg) 24SEP2020 BNT162b2 (30 μg ) 10051213 C4591001 1005 10051213 >55 03SEP2020 251634 Placebo 03SEP2020 Placebo 24SEP2020 Placebo 10051214 C4591001 1005 10051214 >55 03SEP2020 251636 BNT162b2 (30 μg) 03SEP2020 BNT162 b2 (30 μg) 10051215 C4591001 1005 10051215 16-55 10SEP2020 80877 Placebo 10SEP2020 Placebo 01OCT2020 Placebo 10051216 C4591001 1005 10051216 16-55 03SEP2020 79923 Placebo 03SEP2020 Placebo 24SEP2020 Placebo 10051217 C4591001 1005 10051217 16-55 03SEP 2020 79916 BNT162b2 (30 μg) 03SEP2020 BNT162b2 (30 μg) 24SEP2020 BNT1 62b2 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 92 FDA-CBER-2021-5683-0024869 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10051218 C4591001 1005 10051218 >55 03SEP2020 251641 Placebo 03SEP2020 Placebo 25SEP2020 Placebo 10051219 C4591001 1005 10051219 16-55 03SEP2020 80873 BNT162b2 (30 μg) 03SE P2020 BNT162b2 (30 μg) 24SEP2020 BNT162b2 (30 μg) 10051220 C4591001 1005 10051220 16-55 12OCT2020 80882 Placebo 12OCT2020 Placebo 02NOV2020 Placebo 10051221 C4591001 1005 10051221 16-55 12OCT2020 106314 Placebo 12OCT2020 Placebo 03NOV2020 Placebo 100512 22 C4591001 1005 10051222 16-55 12OCT2020 80878 BNT162b2 (30 μg) 12OC T2020 BNT162b2 (30 μg) 02NOV2020 BNT162b2 (30 μg) 10051223 C4591001 1005 10051223 16-55 12OCT2020 106316 BNT162b2 (30 μg) 12OCT2020 BNT162b2 (30 μg) 04NOV2020 BNT162b2 (30 μg) 10051224 C4591001 1005 10051224 16-55 12OCT2020 106315 Placebo 12OCT2020 Place bo 04NOV2020 Placebo 10051225 C4591001 1005 10051225 16-55 12OCT2020 106322 BNT162b2 (30 μg) 12OCT2020 BNT162b2 (30 μg) 02NOV2020 BNT162b2 (30 μg) 10051226 C4591001 1005 10051226 16-55 12OCT2020 106409 Placebo 12OCT2020 Placebo 04NOV2020 Placebo 1005122 7 C4591001 1005 100512 27 >55 12OCT2020 268569 Placebo 12OCT2020 Placebo 03NOV2020 Placebo 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 93 FDA-CBER-2021-5683-0024870 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10051228 C4591001 1005 10051228 16-55 12OCT2020 106414 BNT162b2 (30 μg) 12OCT2020 BNT162b2 (30 μ g) 02NOV2020 BNT162b2 (30 μg) 10051229 C4591001 1005 10051229 >55 12OCT2020 268571 BNT162b2 (30 μg) 12OCT2020 BNT162b2 (30 μg) 02NOV2020 BNT162b2 (30 μg) 10051230 C4591001 1005 10051230 >55 12OCT2020 268573 BNT162b2 (30 μg) 12OCT2020 BNT162b2 (30 μg) 02NOV2020 BNT162b2 (30 μg) 10051231 C4591001 1005 10051231 >55 12OCT202 0 268575 Placebo 12OCT2020 Placebo 02NOV2020 Placebo 10051232 C4591001 1005 10051232 16-55 12OCT2020 106416 Placebo 12OCT2020 Placebo 02NOV2020 Placebo 10051233 C4591001 1005 10051233 16-55 12OCT2020 106418 BNT162b2 (30 μg) 12OCT2020 BNT162b2 (30 μg) 02NOV2020 BNT162b2 (30 μg) 10051234 C4591001 1005 10051234 >55 12OCT2020 268686 Placebo 12OCT2020 Placebo 02NOV2020 Placebo 10051235 C4591001 1005 10051235 16-55 12OCT2020 106685 Placebo 12OCT2020 Placebo 02NOV2020 Placebo 10051236 C4591001 1005 10051236 16-55 13OCT2020 106687 BNT162b2 (30 μg) 13OCT2020 BNT162b2 (30 μg) 03NOV2020 BNT162b2 (30 μg) 10051237 C4591001 1005 10051237 16-55 13OCT2020 106691 BNT162b2 (30 μg) 13OCT2020 BNT162b2 (30 μg) 02NOV2020 BNT162b2 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 94 FDA-CBER-2021-5683-0024871 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10051238 C4591001 1005 10051238 16-55 13OCT2020 106696 Placebo 13OCT2020 Placebo 03NOV2020 Placebo 10051239 C4591001 1005 10051239 >55 13OCT2020 268687 BNT162b2 (30 μg) 13OCT2020 BNT162b2 (30 μg) 03NOV2020 BNT162b2 (30 μg ) 10051240 C4591001 1005 10051240 16-55 13OCT2020 107157 Placebo 13OCT2020 Placebo 03NOV2020 Placebo 10051241 C4591001 1005 10051241 16-55 13OCT2020 107153 BNT162b2 (30 μg) 13OCT2020 BNT162b2 (30 μg) 03NOV2020 BNT162b2 (30 μg) 10051242 C4591001 1005 10051242 16-55 13OCT2020 107159 Placebo 13OCT2020 Placebo 03NOV2020 Placebo 10051243 C4591001 1005 10051243 16-55 13OCT2020 107160 BNT162b2 (30 μg) 13OCT2020 BNT162b2 (30 μg) 04NOV2020 BNT162b2 (30 μg) 10051244 C4591001 1005 10051244 16-55 13OCT2020 107246 BNT162b2 (30 μg) 13OCT2020 BNT162b2 (30 μg) 02NOV2020 BNT162b2 (30 μg ) 10051245 C4591001 1005 10051245 16-55 13OCT2020 107245 Placebo 13OCT2020 Placebo 03NOV2020 Placebo 10051246 C4591001 1005 10051246 16-55 13OCT2020 107241 BNT162b2 (30 μg) 13OCT2020 BNT162b2 (30 μg) 02NOV2020 BNT162b2 (30 μg) 10051247 C4591001 1005 10051247 >55 13OCT2020 268695 BNT162b2 (30 μg) 13OCT2020 BNT162b2 (30 μg) 05NOV2020 BNT162b2 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 95 FDA-CBER-2021-5683-0024872 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10051248 C4591001 1005 10051248 16-55 14OCT2020 107248 Placebo 14OCT2020 Placebo 03NOV20 20 Placebo 10051249 C4591001 1005 10051249 >55 14OCT2020 268696 Placebo 14OCT2020 Placebo 04NOV2020 Placebo 10051250 C4591001 1005 10051250 >55 14OCT2020 269130 Placebo 14OCT2020 Placebo 04NOV2020 Placebo 10051251 C4591001 1005 10051251 16-55 14OCT2020 107406 Placebo 14OCT2020 Placebo 05NOV2020 Placebo 10051252 C4591001 1005 10051252 >55 14OCT2020 269131 Placebo 14OCT2020 Placebo 04NOV2020 Placebo 10051253 C4591001 1005 10051253 >55 14OCT2020 269133 BNT162b2 (30 μg) 14OCT2020 BNT162b2 (30 μg) 05NOV2020 BNT162b2 (30 μg) 10051254 C4591001 1005 10051254 16-55 14OCT2020 107409 Placebo 14OCT2020 Placebo 05NOV2020 Placebo 10051255 C4591001 1005 10051255 >55 14OCT2020 269347 Placebo 14OCT2020 Placebo 03NOV 2020 Placebo 10051256 C4591001 1005 10051256 >55 14OCT2020 269138 BNT162b2 (30 μg) 14OCT2020 BNT162b2 (30 μg) 04NOV2020 BNT162b2 (30 μg) 10051257 C4591001 1005 10051257 16-55 14OCT2020 107410 BNT162b2 (30 μg) 14OCT2020 BNT162b2 (30 μg) 05NOV2020 BNT162b2 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 96 FDA-CBER-2021-5683-0024873 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10051258 C4591001 1005 10051258 >55 14OCT2020 269350 BNT162b2 (30 μg) 14OCT2020 BNT162b2 (30 μg) 04NOV2020 BNT162b2 (30 μg) 10051259 C4591001 1005 10051259 16-55 14OCT2020 107414 BNT162b2 (30 μg) 14OCT2020 BNT162b2 (30 μg) 04NOV2020 BNT162b2 (30 μg) 10051260 C4591001 1005 10051260 16-55 14OCT2020 107790 BNT162b2 (30 μg) 14OCT2020 BNT162b2 (30 μg) 04NOV2020 BNT162b2 (30 μg) 10051261 C4591001 1005 10051261 >55 14OCT2020 269351 BNT162b2 (30 μg) 14OCT2020 BNT162b2 (30 μg) 02NOV2020 BNT162b2 (30 μg) 10051262 C4591001 1005 10051262 >55 15OCT2020 269354 Placebo 15OCT2020 Placebo 05NOV2020 Placebo 10051263 C4591001 1005 10051263 >55 15OCT2020 269599 BNT162b2 (30 μg) 15OCT2020 BNT162b2 (30 μg) 05NOV2020 BNT162b2 (30 μg) 10051264 C4591001 1005 10051264 16-55 15OCT2020 107793 Placebo 15OCT2020 Placebo 04NOV2020 Placebo 10051265 C4591001 1005 10051265 >55 15OCT2020 269603 BNT162b2 (30 μg) 15OCT2020 BNT162b2 (30 μg) 05NOV2020 BNT162b2 (30 μg) 10051266 C4591001 1005 10051266 >55 15OCT2020 269607 Placebo 15OCT2020 Placebo 05NOV2020 Placebo 10051267 C4591001 1005 10051267 16-55 15OCT2020 107796 BNT162b2 (30 μg) 15OCT2020 BNT162b2 (30 μg) 03NOV2020 BNT162b2 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 97 FDA-CBER-2021-5683-0024874 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10051268 C4591001 1005 10051268 16-55 15OCT2020 107797 Placebo 15OCT2020 Placebo 05NOV2020 Placebo 10051269 C4591001 1005 10051269 >55 15OCT2020 269608 Placebo 15OCT2020 Placebo 03NOV2020 Placebo 10051270 C4591001 1005 10051270 16-55 15OCT2020 108269 Placebo 15OCT2020 Placebo 03NOV2020 Placebo 10051271 C4591001 1005 10051271 >55 15OCT2020 26988 2 BNT162b2 (30 μg) 15OCT2020 BNT162b2 (30 μg) 05NOV2020 BNT162b2 (30 μg) 10051272 C4591001 1005 10051272 >55 15OCT2020 269873 BNT162b2 (30 μg) 15OCT2020 BNT162b2 (30 μg) 03NOV2020 BNT162b2 (30 μg) 10051273 C4591001 1005 10051273 16-55 15OCT2020 108272 Placebo 15OCT2020 Placebo 03NOV2020 Placebo 10051274 C4591001 1005 10051274 16-55 15OCT2020 108277 BNT162b2 (30 μg) 15OCT2020 BNT162b2 (30 μg) 03NOV2020 BNT162b2 (30 μg) 10051275 C4591001 1005 10051275 >55 15OCT2020 269883 Placebo 15OCT2020 Placebo 04NOV2020 Placebo 10051276 C4591001 1005 10051276 16-55 15OCT2020 108425 Placebo 15OCT2020 Placebo 04NOV2020 Placebo 10051277 C4591001 1005 10051277 16-55 15OCT2020 108278 BNT162b2 (30 μg) 15OCT2020 BNT162b2 (30 μg) 06NOV2020 BNT162b2 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 98 FDA-CBER-2021-5683-0024875 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10051278 C4591001 1005 10051278 >55 15OCT2020 269884 Placebo 15OCT2020 Placebo 04NOV2020 Placebo 10051280 C4591001 1005 10051280 16-55 16OCT2020 108428 BNT162b2 (30 μg) 16OCT2020 BNT162b2 (30 μg) 05NOV2020 BNT162b2 (30 μg) 10051281 C4591001 1005 10051281 16-55 16OCT2020 108429 Placebo 16OCT2020 Placebo 06NOV2020 Placebo 10051282 C4591001 1005 10051282 >55 16OCT2020 270029 BNT162b2 (30 μg) 16OCT2020 BNT162b2 (30 μg) 06NOV2020 BNT162b2 (30 μg) 10051283 C4591001 1005 10051283 16-55 16OCT2020 108430 BNT162b2 (30 μg) 16OCT2020 BNT162b2 (30 μg) 06NOV2020 BNT162b2 (30 μg) 10051284 C4591001 1005 10051284 >55 16OCT2020 270030 Placebo 16OCT2020 Placebo 06NOV2020 Placebo 10051285 C4591001 1005 10051285 16-55 16OCT2020 109004 BNT162b2 (30 μg) 16OCT2020 BNT162b2 (30 μg) 05NOV2020 BNT 162b2 (30 μg) 10051286 C4591001 1005 10051286 >55 16OCT2020 270032 BNT162b2 (30 μg) 16OCT2020 BNT162b2 (30 μg) 06NOV2020 BNT162b2 (30 μg) 10051287 C459 1001 1005 10051287 >55 16OCT2020 270035 Placebo 16OCT2020 Placebo 04NOV2020 Placebo 10051288 C4591001 1005 10051288 16-55 16OCT2020 109006 Placebo 16OCT2020 Placebo 06NOV2020 Placebo 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 99 FDA-CBER-2021-5683-0024876 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10051289 C4591001 1005 10051289 16-55 16OCT2020 109010 Placebo 16OCT2020 Placebo 04NOV2020 Placebo 10051290 C4591001 1005 10051290 16-55 16OCT2020 109012 BNT162b2 (30 μg) 16OCT2020 BNT162b2 (30 μg) 04NOV2020 BNT162b2 (30 μg) 10051291 C4591001 1005 10051291 16-55 19OCT2020 109823 BNT162b2 (30 μg) 19OCT2020 BNT162b2 (30 μg) 09NOV2020 BNT162b2 (30 μg) 10051292 C4591001 1005 10051292 16-55 19OCT2020 109825 BNT162b2 (30 μg) 19OC T2020 BNT162b2 (30 μg) 09NOV2020 BNT162b2 (30 μg) 10051293 C4591001 1005 10051293 >55 19OCT2020 270739 BNT162b2 (30 μg) 19OCT2020 BNT162b2 (30 μg) 10051294 C4591001 1005 10051294 16-55 19OCT2020 109827 Placebo 19OCT2020 Placebo 10NOV2020 Placebo 1005 1295 C4591001 1005 10051295 16-55 19OCT2020 109828 Placebo 19OCT2020 Placebo 09NOV2020 Placebo 10051296 C4591001 1005 10051296 >55 19OCT2020 270741 Placebo 19OCT2020 Placebo 09NOV2020 Placebo 10051298 C4591001 1005 10051298 >55 19OCT2020 270744 BNT162b2 (30 μg) 19OCT2020 BNT162b2 (30 μg) 09NOV2020 BNT162b2 (30 μg) 10051299 C4591001 1005 10051299 >55 19OCT2020 270747 Placebo 19OCT2020 Placebo 09NOV2020 Placebo 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 100 FDA-CBER-2021-5683-0024877 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10051300 C4591001 1005 10051300 >55 19OCT2020 270917 BNT162b2 (30 μg) 19OCT2020 BNT162b2 (30 μg ) 09NOV2020 BNT162b2 (30 μg) 10051301 C4591001 1005 10051301 16-55 19OCT2020 110106 BNT162b2 (30 μg) 19OCT2020 BNT162b2 (30 μg) 09NOV2020 BNT162b2 (30 μg) 10051302 C4591001 1005 10051302 16-55 19OCT2020 110107 BNT162b2 (30 μg) 19OCT2020 BNT162b2 (30 μg) 09NOV2020 BNT162b2 (30 μg) 10051303 C4591001 1005 10051303 >55 19OCT2020 270920 Placebo 19OCT2020 Placebo 09NOV2020 Placebo 10051304 C4591001 1005 10051304 >55 19OCT2020 270926 BNT162b2 (30 μg) 19OCT2020 BNT162b2 (30 μg) 09NOV2020 BNT162b2 (30 μg) 10051 306 C4591001 1005 10051306 >55 19OCT2020 270928 Placebo 19OCT2020 Placebo 09NOV2020 Placebo 10051307 C4591001 1005 10051307 >55 19OCT2020 271014 Placebo 19OCT2020 Placebo 10NOV2020 Placebo 10051308 C4591001 1005 10051308 16-55 19OCT2020 110110 Placebo 19OCT2020 Placebo 10051309 C4591001 1005 10051309 >55 19OCT2020 271017 Placebo 19OCT2020 Placebo 09NOV2020 Placebo 10051310 C4591001 1005 10051310 16-55 19OCT2020 110114 Placebo 19OCT2020 Placebo 09NOV2020 Placebo 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 101 FDA-CBER-2021-5683-0024878 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10051311 C4591001 1005 10051311 16-55 19OCT2020 110432 Placebo 19OCT2020 Placebo 09NOV2020 Placebo 10051312 C4591001 1005 10051312 >55 19OCT2020 271021 BNT162b2 (30 μg) 19OCT2020 BNT162b2 (30 μg) 13NOV2020 BNT162b2 (30 μg) 10051313 C4591001 1005 10051313 >55 19OCT2020 271023 BNT162b2 (30 μg) 19OCT2020 BNT162b2 (30 μg) 09NOV2020 BNT162b2 (30 μg) 10051314 C4591001 1005 10051314 16-55 19OCT2020 110435 BNT162b2 (30 μg) 19OCT2020 BNT162b2 (30 μg) 09NOV2020 BNT162b2 (30 μg) 10051315 C4591001 1005 10051315 16-55 20OCT2020 110436 BNT162b2 (30 μg) 20OCT2020 BNT162b2 (30 μg) 09NOV2020 BNT162b2 (30 μg) 10051316 C4591001 1005 10051316 16-55 20OCT2020 110440 Placebo 20OCT2020 Placebo 11NOV2020 Placebo 10051318 C4591001 1005 10051318 16-55 20OCT2020 110705 BNT162b2 (30 μg) 20OCT2020 BNT162b2 (30 μg) 11NOV2020 BNT162b2 (30 μg) 10051319 C4591001 1005 10051319 >55 20OCT2020 271237 BNT162b2 (30 μg) 20OCT2020 BNT162b2 (30 μg) 12NOV2020 BNT162b2 (30 μg) 10051320 C4591001 1005 10051320 >55 20OCT2020 271232 BNT162b2 (30 μg) 20OCT2020 BNT162b2 (30 μg) 10NOV2020 BNT162b2 (30 μg) 10051321 C4591001 1005 10051321 >55 20OCT2020 271234 Placebo 20OCT2020 Placebo 11NOV2020 Placebo 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 102 FDA-CBER-2021-5683-0024879 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10051322 C4591001 1005 10051322 16-55 20OCT2020 110707 BNT162b2 (30 μg) 20OCT2020 BNT162b2 (30 μg) 10NOV2020 BNT162b2 (30 μg) 10051323 C4591001 1005 10051323 16-55 20OCT2020 110712 Placebo 20OCT2020 Placebo 09NOV2020 Placebo 10051324 C4591001 1005 10051324 >55 20OCT2020 271238 Placebo 20OCT2020 Placebo 10NOV2020 Placebo 10051325 C4591001 1005 10051325 >55 20OCT2020 271333 Placebo 20OCT2020 Placebo 09NOV2020 Placebo 10051326 C4591001 1005 10051326 16-55 20OCT2020 110716 Placebo 20OCT2020 Placebo 10NOV2020 Placebo 10051327 C4591001 1005 10051327 >55 20OCT2020 271334 BNT162b2 (30 μg) 20OCT2020 BNT162b2 (30 μg) 10NOV2020 BNT162b2 (30 μg) 10051329 C4591001 1005 10051329 >55 20OCT2020 271335 BNT162b2 (30 μg) 20OCT2020 BNT162b2 (30 μg) 11NOV2020 BNT162b2 (30 μg) 10051330 C4591001 1005 10051330 >55 20OCT2020 271336 Placeb o 20OCT2020 Placebo 10NOV2020 Placebo 10051331 C4591001 1005 10051331 16-55 20OCT2020 110911 BNT162b2 (30 μg) 20OCT2020 BNT162b2 (30 μg) 10NOV2020 BNT162b2 (30 μg) 10051332 C4591001 1005 10051332 16-55 20OCT2020 110913 BNT162b2 (30 μg) 20OCT2020 BNT162b2 (30 μg) 10NOV2020 BNT162b2 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 103 FDA-CBER-2021-5683-0024880 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10051333 C4591001 1005 10051333 >55 20OCT2020 271501 Placebo 20OCT2020 Placebo 11NOV2020 Placebo 10051334 C4591001 1005 10051334 >55 20OCT2020 271502 BNT162b2 (30 μg) 20OCT2020 BNT162b2 (30 μg) 10NOV2020 BNT162b2 (30 μ g) 10051335 C4591001 1005 10051335 16-55 21OCT2020 110915 Placebo 21OCT2020 Placebo 11NOV2020 Placebo 10051336 C4591001 1005 10051336 >55 21OCT2020 271503 BNT162b2 (30 μg) 21OCT2020 BNT162b2 (30 μg) 11NOV2020 BNT162b2 (30 μg) 10051337 C4591001 1005 1005 1337 >55 21OCT2020 271504 Placebo 21OCT2020 Placebo 10NOV2020 Placebo 10051338 C4591001 1005 10051338 >55 21OCT2020 271758 Placebo 21OCT2020 Placebo 10051340 C4591001 1005 10051340 16-55 21OCT2020 110919 Placebo 21OCT2020 Placebo 11NOV2020 Placebo 10051341 C4591001 1005 10051341 16-55 21OCT2020 111573 Placebo 21OCT2020 Placebo 10051342 C4591001 1005 10051342 >55 21OCT2020 271760 Placebo 21OCT2020 Placebo 10NOV2020 Placebo 10051343 C4591001 1005 10051343 16-55 21OCT2020 111578 BNT162b2 (30 μg) 21OCT2020 BNT162b2 (30 μg) 11NOV2020 BNT162b2 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 104 FDA-CBER-2021-5683-0024881 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10051344 C4591001 1005 10051344 >55 21OCT2020 271763 BNT162b2 (30 μg) 21OCT2020 BNT162b2 (30 μg) 09NOV2020 BNT162b2 (30 μg) 10051345 C4591001 1005 10051345 16-55 21OCT2020 111579 Placebo 21OCT2020 Placebo 12NOV2020 Placebo 10051346 C4591001 1005 10051346 16-55 21OCT2020 111580 BNT162b2 (30 μg) 21OCT2020 BNT162b2 (30 μg) 13NOV2020 BNT162b2 (30 μg) 10051347 C4591001 1005 10051347 >55 22OCT2020 272165 Placebo 22OCT2020 Placebo 12NOV2020 Placebo 10051348 C4591001 1005 10051348 >55 22OCT2020 271766 BNT162b2 (30 μg) 22OCT2020 BNT162b2 (30 μg) 12NOV2020 BNT162b2 (30 μg) 10051349 C4591001 1005 10051349 16-55 22OCT2020 112037 Placebo 22OCT2020 Placebo 11NOV2020 Placebo 10051350 C4591001 1005 10051350 16-55 22OCT2020 112038 BNT162b2 (30 μg) 22OCT2020 BNT162b2 (30 μg) 11NOV2020 BNT162b2 (30 μg) 10051351 C4591001 1005 10051351 >55 22OCT2020 272166 BNT162b2 (30 μg) 22OCT2020 BNT162b2 (30 μg) 10NOV2020 BNT162b2 (30 μg) 10051353 C4591001 1005 10051353 >55 22OCT2020 272172 Placebo 22OCT2020 Placebo 10NOV2020 Placebo 10051354 C4591001 1005 10051354 16-55 22OCT2020 112040 Placebo 22OCT2020 Placebo 12NOV2020 Placebo 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 105 FDA-CBER-2021-5683-0024882 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10051355 C4591001 1005 10051355 >55 22OCT2020 272175 BNT162b2 (30 μg) 22OCT2020 BNT 162b2 (30 μg) 11NOV2020 BNT162b2 (30 μg) 10051356 C4591001 1005 10051356 16-55 22OCT2020 112042 BNT162b2 (30 μg) 22OCT2020 BNT162b2 (30 μg) 12NOV2020 BNT162b2 (30 μg) 10051357 C4591001 1005 10051357 16-55 22OCT2020 112290 BNT162b2 (30 μg) 22OCT2020 BNT16 2b2 (30 μg) 12NOV2020 BNT162b2 (30 μg) 10051358 C4591001 1005 10051358 16-55 22OCT2020 112295 Placebo 22OCT2020 Placebo 13NOV2020 Placebo 10051360 C4591001 1005 10051360 >55 22OCT2020 272454 Placebo 22OCT2020 Placebo 12NOV2020 Placebo 10051361 C4591001 1005 10051361 16-55 22OCT2020 112297 BNT162b2 (30 μg) 22OCT2020 BNT162b2 (30 μg) 11NOV2020 BNT162b2 (30 μg) 10051362 C4591001 1005 10051362 16-55 23OCT2020 112300 Placebo 23OCT2020 Placebo 13NOV2020 Placebo 10051363 C4591001 1005 10051363 16-55 23OCT2020 112711 Placebo 23OCT2020 Placebo 13NOV2020 Placebo 10051364 C4591001 1005 10051364 16-55 23OCT2020 112714 Placebo 23OCT2020 Placebo 13NOV2020 Placebo 10051365 C4591001 1005 10051365 16-55 23OCT2020 112715 BNT162b2 (30 μg) 23OCT2020 BNT162b2 (30 μg) 11NO V2020 BNT162b2 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 106 FDA-CBER-2021-5683-0024883 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10051366 C4591001 1005 10051366 16-55 23OCT2020 112717 BNT162b2 (30 μg) 23OCT2020 BNT162b2 (30 μg) 13NOV2020 BNT162b2 (30 μg) 10051367 C4591001 1005 10051367 >55 23OCT2020 272457 Placebo 23OCT2020 Placebo 12NOV2020 Placebo 1005136 8 C4591001 1005 10051368 16-55 23OCT2020 112976 Placebo 23OCT2020 Placebo 13NOV2020 Placebo 10051369 C4591001 1005 10051369 16-55 26OCT2020 112979 BNT162b2 (30 μg) 26OCT2020 BNT162b2 (30 μg) 10051370 C4591001 1005 10051370 16-55 26OCT2020 112984 Place bo 26OCT2020 Placebo 10051371 C4591001 1005 10051371 16-55 26OCT2020 112983 BNT162b2 (30 μg) 26OCT2020 BNT162b2 (30 μg) 10051372 C4591001 1005 10051372 >55 26OCT2020 272464 BNT162b2 (30 μg) 26OCT2020 BNT162b2 (30 μg) 10051373 C4591001 1005 1005 1373 >55 26OCT2020 272463 BNT162b2 (30 μg) 26OCT2020 BNT162b2 (30 μg) 10051374 C4591001 1005 10051374 >55 26OCT2020 273042 BNT162b2 (30 μg) 26OCT2020 BNT162b2 (30 μg) 10051375 C4591001 1005 10051375 >55 26OCT2020 273043 Placebo 26OCT2020 Placebo 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 107 FDA-CBER-2021-5683-0024884 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10051377 C4591001 1005 10051377 16-55 27OCT2020 113982 Placebo 27OCT2020 Placebo 10051378 C4591001 1005 10051378 16-55 27OCT2020 113984 BNT162b2 (30 μg) 27OCT2020 BNT162b2 (30 μg) 10051379 C4591001 1005 10051379 >55 27OCT2020 273047 Placebo 27OCT 2020 Placebo 10051380 C4591001 1005 10051380 16-55 27OCT2020 113991 Placebo 27OCT2020 Placebo 10051381 C4591001 1005 10051381 16-55 28OCT2020 113992 BNT162b2 (30 μg) 10051382 C4591001 1005 10051382 >55 28OCT2020 273051 BNT162b2 (30 μg) 28OCT 2020 BNT162b2 (30 μg) 10051385 C4591001 1005 10051385 16-55 28OCT2020 114463 BNT162b2 (30 μg) 28OCT2020 BNT162b2 (30 μg) 10051386 C4591001 1005 10051386 16-55 28OCT2020 114465 Placebo 28OCT2020 Placebo 10051387 C4591001 1005 10051387 >55 29OCT2 020 273643 BNT162b2 (30 μg) 29OCT2020 BNT162b2 (30 μg) 10051389 C4591001 1005 10051389 >55 29OCT2020 273645 BNT162b2 (30 μg) 29OCT2020 BNT162b2 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 108 FDA-CBER-2021-5683-0024885 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10051390 C4591001 1005 10051390 16-55 30OCT2020 273647 Placebo 30OCT2020 Placebo 10051391 C4591001 1005 10051391 >55 30OCT2020 273646 Placebo 30OCT2020 Placebo 10051392 C4591001 1005 10051392 >55 30OCT2020 273857 Placebo 30OCT2020 Placebo 10051393 C4591001 1005 10051393 16-55 30OCT2020 114466 BNT162b2 (30 μg) 30OCT2020 BNT162b2 (30 μg) 10051394 C4591001 1005 10051394 16-55 02NOV2020 114472 Placebo 02NOV2020 Placebo 10051395 C4591001 1005 10051395 >55 02NOV2020 273860 BNT162b2 (30 μg) 02NOV2020 BNT162b2 (30 μg) 10051396 C4591001 1005 10051396 16-55 02NOV2020 115315 BNT162b2 (30 μg) 02NOV2020 BNT162b2 (30 μg) 10051397 C4591001 1005 10051397 16-55 02NOV2020 115317 Placebo 02NOV2020 Placebo 10051398 C4591001 1005 10051398 16-55 03NOV2020 115318 Placebo 03NOV2020 Placebo 10051399 C4591001 1005 10051399 >55 03NOV2020 27386 6 Placebo 03NOV2020 Placebo 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 109 FDA-CBER-2021-5683-0024886 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10051400 C4591001 1005 10051400 16-55 03NOV2020 115320 BNT162b2 (30 μg) 03NOV2020 BNT162b2 (30 μg) 10051402 C4591001 1005 10051402 >55 03NOV2020 273868 BNT162b2 (30 μg) 03NOV2020 BNT162b2 (30 μg) 10051403 C4591001 1005 10051403 >55 04NOV2020 274026 BNT162b2 (30 μg) 04NOV2020 BNT162b2 (30 μg) 10051405 C4591001 1005 10051405 >55 06NOV2020 274029 Placebo 06NOV2020 Placebo 10051406 C4591001 1005 10051406 >55 09NOV2020 274031 BNT162b2 (30 μg) 09NOV2020 BNT162b2 (30 μg) 10051407 C4591001 1005 10051407 16-55 11NOV2020 116093 Placebo 11NOV2020 Placebo 10051408 C4591001 1005 10051408 16-55 11NOV2020 116096 BNT162b2 (30 μg) 11NOV2020 BNT162b2 (30 μg) 10061001 C4591001 1006 10061001 >55 06AUG2020 223782 Placeb o 06AUG2020 Placebo 25AUG2020 Placebo 10061002 C4591001 1006 10061002 >55 06AUG2020 223783 Placebo 06AUG2020 Placebo 25AUG2020 Placebo 10061003 C4591001 1006 10061003 >55 10AUG2020 223787 BNT162b2 (30 μg) 10AUG2020 BNT162b2 (30 μg) 01SEP2020 BNT162b2 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 110 FDA-CBER-2021-5683-0024887 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10061004 C4591001 1006 10061004 >55 10AUG2020 223789 BNT162b2 (30 μg) 10AUG2020 BNT162b2 (30 μg) 01SEP2020 BNT162b2 (30 μg) 10061005 C4591001 1006 10061005 16-55 10AUG2020 45485 Placebo 10AUG2020 Placebo 31AUG2020 Placebo 10061006 C4591001 1006 10061006 >55 10AUG2020 225005 BNT162b2 (30 μg) 10AUG2020 BNT162b2 (30 μg) 31AUG2020 BNT162b2 (30 μg) 10061007 C4591001 1006 10061007 16-55 10AUG2020 45487 BNT162b2 (30 μg) 10AUG2020 BNT162b2 (30 μg) 31AUG2020 BNT162b2 (30 μg) 10061008 C4591001 1006 10061008 16-55 10AUG2020 45490 Placebo 10AUG2020 Placebo 31AUG2020 Placebo 10061009 C4591001 1006 10061009 16-55 10AUG2020 45495 BNT162b2 (30 μg) 10AUG2020 BNT162b2 (30 μg) 02SEP2020 BNT162b2 (30 μg) 10061010 C4591001 1006 10061010 >55 10AUG2020 225006 BNT162b2 (30 μg) 10AUG2020 BNT162b2 (30 μg) 31AUG2020 BNT162b2 (30 μg) 10061011 C4591001 1006 10061011 16-55 11AUG2020 46289 BNT162b2 (30 μg) 11AUG2020 BNT162b2 (30 μg) 31AUG2020 BNT162b2 (30 μg) 10061012 C4591001 1006 10061012 16-55 11AUG2020 46292 Placebo 11AUG 2020 Placebo 31AUG2020 Placebo 10061013 C4591001 1006 10061013 16-55 11AUG2020 46294 Placebo 11AUG2020 Placebo 31AUG2020 Placebo 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 111 FDA-CBER-2021-5683-0024888 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10061014 C4591001 1006 10061014 16-55 11AUG2020 46296 BNT162b2 (30 μg) 11AUG2020 BNT162b2 (30 μg) 31AUG2020 BNT162b2 (30 μg) 10061015 C4591001 1006 10061015 16-55 11AUG2020 46865 BNT162b2 (30 μg) 11AUG2020 BNT162b2 (30 μg) 01SEP2020 BNT162b2 (30 μg) 10061016 C4591001 1006 10061016 >55 11AUG2020 225010 Placebo 11AUG2020 Placebo 31AUG2020 Placebo 10061017 C4591001 1006 10061017 >55 11AUG2020 225013 Placebo 11AUG2020 Placebo 01SEP2020 Placebo 10061018 C4591001 1006 10061018 16-55 11AUG2020 46868 Placebo 11AUG2020 Placebo 31AUG2020 Placebo 10061019 C4591001 1006 10061019 16-55 12AUG2020 46869 BNT162b2 (30 μg) 12AUG2020 BNT162b2 (30 μg) 03SEP2020 BNT162b2 (30 μg) 10061020 C4591001 1006 10061020 >55 12AUG2020 226866 Placebo 12AUG2020 Placebo 10061021 C4591001 1006 10061021 16-55 12AUG2020 46874 Placebo 12AUG2020 Placebo 01SEP2020 Placebo 10061022 C4591001 1006 10061022 16-55 12AUG2020 47813 Placebo 12AUG2020 Placebo 31AUG2020 Placebo 10061023 C4591001 1006 10061023 16-55 12AUG2020 47819 Placebo 12AUG2020 Placebo 31AUG2020 Placebo 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 112 FDA-CBER-2021-5683-0024889 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10061024 C4591001 1006 10061024 16-55 12AUG2020 47820 BNT162b2 (30 μg) 12AUG2020 BNT162b2 (30 μg ) 31AUG2020 BNT162b2 (30 μg) 10061025 C4591001 1006 10061025 >55 12AUG2020 226870 Placebo 12AUG2020 Placebo 01SEP2020 Placebo 10061027 C4591001 1006 10061027 >55 13AUG2020 226873 BNT162b2 (30 μg) 13AUG2020 BNT162b2 (30 μg) 04SEP2020 BNT162b2 (30 μg) 10061028 C4591001 1006 10061028 16-55 13AUG2020 47823 BNT162b2 (30 μg) 13AUG2020 BNT162b2 (30 μg) 03SEP2020 BNT162b2 (30 μg) 10061029 C4591001 1006 10061029 >55 13AUG2020 226875 BNT162b2 (30 μg) 13AUG2020 BNT162b2 (30 μg) 03SEP2020 BNT162b2 (30 μg) 10061030 C4591001 1006 10061030 >55 13AUG2020 228500 Placebo 13AUG2020 Placebo 03SEP2020 Placebo 10061031 C4591001 1006 10061031 16-55 13AUG2020 49714 Placebo 13AUG2020 Placebo 04SEP2020 Placebo 10061032 C4591001 1006 10061032 16-55 13AUG2020 49718 BNT162b2 (30 μg) 13AUG2020 BNT162b2 (30 μg) 04SEP2020 BNT162b2 (30 μg) 10061033 C4591001 1006 10061033 16-55 13AUG2020 49712 BNT162b2 (30 μg) 13AUG2020 BNT162b2 (30 μg) 04SEP2020 BNT162b2 (30 μg) 10061034 C4591001 1006 10061034 >55 14AUG2020 228501 BNT162b2 (30 μg) 14AUG2020 BNT162b2 (30 μg) 02SEP2020 BNT162b2 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 113 FDA-CBER-2021-5683-0024890 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10061035 C4591001 1006 10061035 >55 14AUG2020 228503 BNT162b2 (30 μg) 14AUG2020 BNT162b2 (30 μg) 04SEP2020 BNT162b2 (30 μg) 10061036 C4591001 1006 10061036 16-55 14AUG2020 49719 Placebo 14AUG2020 Place bo 04SEP2020 Placebo 10061037 C4591001 1006 10061037 16-55 14AUG2020 50868 Placebo 14AUG2020 Placebo 04SEP2020 Placebo 10061039 C4591001 1006 10061039 >55 14AUG2020 228507 Placebo 14AUG2020 Placebo 04SEP2020 Placebo 10061040 C4591001 1006 10061040 16-55 14AUG2020 50870 Placebo 14AUG2020 Placebo 04SEP2020 Placebo 10061041 C4591001 1006 10061041 16-55 14AUG2020 50871 BNT162b2 (30 μg) 14AUG2020 BNT162b2 (30 μg) 04SEP2020 BNT162b2 (30 μg) 10061043 C4591001 1006 10061043 16-55 17AUG2020 50872 BNT162b2 (30 μg) 17AUG2020 BNT162b2 (30 μg) 10SEP2020 BNT162b2 (30 μg) 10061044 C4591001 1006 10061044 >55 17AUG2020 230657 BNT16 2b2 (30 μg) 17AUG2020 BNT162b2 (30 μg) 09SEP2020 BNT162b2 (30 μg) 10061045 C4591001 1006 10061045 >55 17AUG2020 230658 BNT162b2 (30 μg) 17AUG2020 BNT162b2 (30 μg) 09SEP2020 BNT162b2 (30 μg) 10061046 C4591001 1006 10061046 >55 17AUG2020 230661 Placebo 17AUG2020 Placebo 08SEP2020 Placebo 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 114 FDA-CBER-2021-5683-0024891 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10061047 C4591001 1006 10061047 >55 17AUG2020 230664 Placebo 17AUG2020 Placebo 08SEP2020 Placebo 10061049 C4591001 1006 10061049 >55 17AUG2020 231223 Placebo 17AUG2020 Placebo 09SEP2020 Placebo 10061050 C4591001 1006 10061050 16-55 17AUG2020 53731 BNT162b2 (30 μg) 17AUG2020 BNT162b2 (30 μg) 09SEP2020 BNT162b2 (30 μg) 10061051 C4591001 1006 10061051 >55 18AUG2020 231226 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 09SEP2020 BNT162b2 (30 μg) 10061052 C4591001 1006 10061052 16-55 18AUG2020 53735 Place bo 18AUG2020 Placebo 08SEP2020 Placebo 10061053 C4591001 1006 10061053 16-55 18AUG2020 53737 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 09SEP2020 BNT162b2 (30 μg) 10061054 C4591001 1006 10061054 16-55 18AUG2020 53738 Placebo 18AUG2020 Placebo 08SEP2020 Placebo 10061055 C4591001 1006 10061055 16-55 18AUG2020 54787 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 10SEP2020 BNT162b2 (30 μg) 10061056 C4591001 1006 10061056 16-55 18AUG2020 54791 Placebo 18AUG2020 Placebo 08SEP2020 Placebo 10061057 C4591001 1006 10061057 16-55 18AUG2020 54788 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 10SEP2020 BNT162b2 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 115 FDA-CBER-2021-5683-0024892 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10061059 C4591001 1006 10061059 >55 18AUG2020 231229 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 08SEP2020 BNT162b2 (30 μg) 10061060 C4591001 1006 1006 1060 >55 18AUG2020 231232 Placebo 18AUG2020 Placebo 08SEP2020 Placebo 10061061 C4591001 1006 10061061 16-55 18AUG2020 54792 Placebo 18AUG2020 Placebo 09SEP2020 Placebo 10061062 C4591001 1006 10061062 16-55 18AUG2020 55590 BNT162b2 (30 μg) 18AUG2020 BNT16 2b2 (30 μg) 09SEP2020 BNT162b2 (30 μg) 10061063 C4591001 1006 10061063 >55 18AUG2020 232793 BNT162b2 (30 μg) 18AUG2020 BNT162b2 (30 μg) 10SEP2020 BNT162b2 (30 μg) 10061064 C4591001 1006 10061064 >55 04SEP2020 248821 Placebo 04SEP2020 Placebo 25SEP2020 Placebo 10061065 C4591001 1006 10061065 >55 19AUG2020 232798 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 09SEP2020 BNT162b2 (30 μg) 10061066 C4591001 1006 10061066 16-55 19AUG2020 55592 Placebo 19AUG2020 Placebo 14SEP2020 Placebo 10061067 C4591001 1006 10061067 16-55 19AUG2020 55593 Placebo 19AUG2020 Placebo 08SEP2020 Placebo 10061068 C4591001 1006 10061068 16-55 19AUG2020 55595 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 09SEP2020 BNT162b2 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 116 FDA-CBER-2021-5683-0024893 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10061069 C4591001 1006 10061069 >55 19AUG2020 232800 Placebo 19AUG2020 Placebo 09SEP2020 Placebo 10061070 C4591001 1006 10061070 16-55 19AUG2020 57392 Placebo 19AUG2020 Placebo 02OCT2020 Placebo 10061071 C4591001 1006 10061071 16-55 19AUG2020 57393 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 15SEP2020 BNT162b 2 (30 μg) 10061073 C4591001 1006 10061073 16-55 19AUG2020 57394 Placebo 19AUG2020 Placebo 10SEP2020 Placebo 10061074 C4591001 1006 10061074 16-55 19AUG2020 57395 BNT162b2 (30 μg) 19AUG2020 BNT162b2 (30 μg) 10SEP2020 BNT162b2 (30 μg) 10061075 C4591001 1006 10061075 16-55 20AUG2020 58337 Placebo 20AUG2020 Placebo 09SEP2020 Placebo 10061076 C4591001 1006 10061076 >55 20AUG2020 232801 Placebo 20AUG2020 Placebo 11SEP2020 Placebo 10061077 C4591001 1006 10061077 >55 20AUG2020 235148 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 10SEP2020 BNT162b2 (30 μg) 10061078 C4591001 1006 10061078 16-55 20AUG2020 58342 Placebo 20AUG2020 Placebo 10SEP2020 Placebo 10061079 C4591001 1006 10061079 16-55 20AUG2020 58343 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 16SEP2020 BNT 162b2 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 117 FDA-CBER-2021-5683-0024894 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10061080 C4591001 1006 10061080 >55 20AUG2020 235149 Placebo 20AUG2020 Placebo 08SEP2020 Placebo 10061081 C4591001 1006 10061081 16-55 20AUG2020 58344 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 11SEP2020 BNT162b2 (30 μg) 10061082 C4591001 1006 10061082 >55 20AUG2020 235152 Placebo 20AUG2020 Placebo 09SEP2020 Placebo 10061083 C4591001 1006 10061083 >55 20AUG2020 235154 BNT162b2 (30 μg) 20AUG2020 BNT162b2 (30 μg) 10SEP2020 BNT162b2 (30 μg) 10061084 C4591001 1006 10061084 16-55 20AUG2020 59827 Placebo 20AUG2020 Placebo 10SEP2020 Placebo 10061086 C4591001 1006 10061086 >55 21AUG2020 236118 Placebo 21AUG2020 Placebo 09SEP2020 Placebo 10061088 C4591001 1006 10061088 16-55 21AUG2020 59828 Placebo 21AUG2020 Placebo 11SEP2020 Placebo 10061089 C4591001 1006 10061089 16-55 21AUG2020 59831 BNT162b2 (30 μg) 21AUG2020 BNT162b2 (30 μg) 10SEP2020 BNT162b2 (30 μg) 10061090 C4591001 1006 10061090 16-55 21AUG2020 59835 BNT162b2 (30 μg) 21AUG2020 BNT162b2 (30 μg) 11SEP2020 BNT162b2 (30 μg) 10061091 C4591001 1006 10061091 16-55 21AUG2020 61613 Placebo 21AUG2020 Placebo 11SEP2020 Placebo 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 118 FDA-CBER-2021-5683-0024895 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10061092 C4591001 1006 10061092 16-55 21AUG2020 61614 Placebo 21AUG2020 Placebo 11SEP2020 Placebo 10061093 C4591001 1006 10061093 16-55 24AUG2020 61616 BNT162b2 (30 μg) 24AUG2020 BNT162b2 (30 μg) 18SEP2020 BNT162b2 (30 μg) 10061094 C4591001 1006 10061094 16-55 24AUG2020 61617 BNT162b2 (30 μg) 24AUG2020 BNT162b2 (30 μg) 18SEP2020 BNT162b2 (30 μg) 10061095 C4591001 1006 10061095 16-55 24AUG2020 63883 Placebo 24AUG2020 Placebo 15SEP2020 Placebo 10061096 C4591001 1006 10061096 16-55 24AUG2020 63885 BNT162b2 (30 μg) 24AUG2020 BNT162b2 (30 μg) 29SEP2020 BNT162b2 (30 μg) 10061097 C4591001 1006 10061097 >55 24AUG2020 236120 BNT162b2 (30 μg) 24AUG2020 BNT162b2 (30 μg) 15SEP2020 BNT162b2 (30 μ g) 10061098 C4591001 1006 10061098 >55 24AUG2020 236124 BNT162b2 (30 μg) 24AUG2020 BNT162b2 (30 μg) 15SEP2020 BNT162b2 (30 μg) 10061099 C4591001 1006 10061099 16-55 24AUG2020 63886 Placebo 24AUG2020 Placebo 15SEP2020 Placebo 10061100 C4591001 1006 10061100 16-55 24AUG2020 63892 BNT1 62b2 (30 μg) 24AUG2020 BNT162b2 (30 μg) 14SEP2020 BNT162b2 (30 μg) 10061101 C4591001 1006 10061101 >55 24AUG2020 236127 Placebo 24AUG2020 Placebo 14SEP2020 Placebo 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 119 FDA-CBER-2021-5683-0024896 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10061102 C4591001 1006 10061102 16-55 24AUG2020 64939 Placebo 24AUG2020 Placebo 14SEP2020 Placebo 10061103 C4591001 1006 10061103 16-55 24AUG2020 64940 BNT162b2 (30 μg) 24AUG2020 BNT162b2 (30 μg) 14SEP2020 BNT162b2 (30 μg) 10061104 C4591001 1006 10061104 16-55 25AUG2020 64944 BNT162b2 (30 μg) 25AUG2020 BNT162b2 (30 μg) 15SEP2020 BNT162b2 (30 μg) 10061105 C4591001 1006 10061105 >55 25AUG2020 239598 Placebo 25AUG2020 Placebo 16SEP2020 Placebo 10061106 C4591001 1006 10061106 16-55 25AUG2020 64947 Placebo 25AUG2020 Placebo 14SEP2020 Placebo 10061107 C4591001 1006 10061107 16-55 25AUG2020 66439 BNT162b2 (30 μg) 25AUG2020 BNT162b2 (30 μg) 15SEP2020 BNT162b2 (30 μg) 10061108 C4591001 1006 10061108 16-55 25AUG2020 66442 BNT162b2 (30 μg) 25AUG2020 BNT162b2 (30 μg) 18SEP2020 BNT162b2 (30 μg) 10061109 C4591001 1006 10061109 16-55 25AUG2020 66446 Placebo 25AUG2020 Placebo 14SEP2020 Placebo 10061110 C4591001 1006 10061110 16-55 25AUG2020 66447 Placebo 25AUG2020 Placebo 17SEP2020 Placebo 10061112 C4591001 1006 10061112 16-55 26AUG2020 67556 BNT162b2 (30 μg) 26AUG2020 BNT162b2 (30 μg) 16SEP2020 BNT162b2 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 120 FDA-CBER-2021-5683-0024897 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10061113 C4591001 1006 10061113 16-55 26AUG2020 67557 BNT162b2 (30 μg) 26AUG2020 BNT162b2 (30 μg) 21SEP2020 BNT162b2 (30 μg) 10061114 C4591001 1006 10061114 16-55 26AUG2020 67561 Placebo 26AUG2020 Placebo 16SEP2020 Placebo 10061115 C4591001 1006 10061115 >55 26AUG2020 239600 BNT162b2 (30 μg) 26AUG2020 BNT162b2 (30 μg) 16SEP2020 BNT162b2 (30 μg) 10061116 C4591001 1006 10061116 16-55 26AUG2020 67562 Placebo 26AUG2020 Placebo 16SEP2020 Placebo 10061117 C4591001 1006 10061117 16-55 26AUG2020 69344 BNT162b2 (30 μg) 26AUG2020 BNT162b2 (30 μg) 14SEP2020 BNT162b2 (30 μg) 10061118 C4591001 1006 10061118 16-55 27AUG2020 69346 Placebo 27AUG2020 Placebo 18SEP2020 Placebo 10061119 C4591001 1006 10061119 >55 27AUG2020 239604 BNT162b2 (30 μg) 27AUG2020 BNT1 62b2 (30 μg) 16SEP2020 BNT162b2 (30 μg) 10061120 C4591001 1006 10061120 >55 27AUG2020 239608 Placebo 27AUG2020 Placebo 16SEP2020 Placebo 10061121 C4591001 1006 10061121 >55 27AUG2020 243930 Placebo 27AUG2020 Placebo 16SEP2020 Placebo 10061122 C4591001 1006 10061122 16-55 27AUG2020 69348 BNT162b2 (30 μg) 27AUG2020 BNT162b2 (30 μg) 18SEP2020 BNT162b2 (30 μg) 090177e1959b1f96\Final\Final On: 24-Nov-2020 13:50 (GMT) Page 121 FDA-CBER-2021-5683-0024898 16.1.7.4 Listing of Randomization Scheme and Actual Vaccine Received – All Subject s Vaccine Received Subject Study Identifiera Subject Age Group (Years) Randomization Date Randomization Number Randomization Vaccine Group Date Dose 1 Date Dose 2 10061123 C4591001 1006 10061123 >55 27AUG2020 243932 BNT162b2 (30 μg) 27AUG2020 BNT162b2 (30 μg) 17SEP2020 BNT162b2 (30 μ g) 10061124 C4591001 1006 10061124 16-55 28AUG2020 69350 Placebo 28AUG2020 Placebo 21SEP2020 Placebo 10061125 C4591001 1006 10061125 >55 28AUG2020 243936 Placebo 28AUG2020 Placebo 18SEP2020 Placebo 10061128 C4591001 1006 10061128 16-55 28AUG2020 73077 BNT162b2 (30 μg) 28AUG2020 BNT162b2 (30 μg) 18SEP2020 BNT162b2 (30 μg) 10061129 C4591001 1006 10061129 16-55 28AUG2020 73076 BNT162b2 (30 μg) 28AUG2020 BNT162b2 (30 μg) 16SEP2020 BNT162b2 (30 μg) 10061130 C4591001 1006 10061130 16-55 28AUG2020 73081 Placebo 28AUG2020 Placebo 18SEP20 20 Placebo 10061131 C4591001 1006 10061131 16-55 …[truncated]